Calculated based on number of publications stored in Pure and citations from Scopus
20042024

Research activity per year

Network

R. Kurzrock

  • University of Texas M.D. Anderson Cancer Center
  • Department of Hematology
  • Texas Children's Hospital
  • Box 0422
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Box 302
  • Unit 455
  • Universityof Texas M. D. Anderson Cancer Center
  • M.D. Anderson Cancer Center
  • University of Texas at Austin
  • University of Texas, M.D. Anderson Cancer Center
  • Moores Cancer Center-University of California San Diego
  • UT M.D. Anderson Cancer Cent.
  • Division of Hematology-Oncology, UC San Diego Moores Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • Phase I Program
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Univ. Texas M. D. Anderson Cancer C.
  • U.T. M.D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer C.
  • University of California San Diego
  • Box # 302
  • Unit 422
  • Box 422
  • Division of Hematology and Oncology, Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Univesity of Texas
  • M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Clinical Immunology and Biological Therapy M.D. Anderson Cancer Center Houston
  • Department of Investigational Cancer Therapeutics, University of Texas, M. D. Anderson Cancer Center
  • Tumor Institute
  • Univ of Texas, MD Anderson Canc Ctr
  • Bristol-Myers Squibb
  • Dana-Farber Cancer Institute
  • UC San Diego Moores Cancer Center
  • University of Texas MD Anderson Cancer Center
  • UT-M. D. Anderson Cancer Center
  • University of California at San Diego
  • Repligen Corporation
  • Johnson and Johnson Pharmaceutical Research and Development
  • the University of Texas M.D. Anderson Hospital
  • U. T. M. D. Anderson Cancer Center
  • The University of Texas, M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Exelixis
  • Box 61
  • Drexel University
  • University of Texas Graduate School of Biomedical Sciences Houston
  • Cancer Center, Box 41
  • Unit 0455
  • Moores Cancer Center - University of California San Diego
  • FC8.2057
  • A Phase I Program
  • M.D. Anderson Hospital
  • Anderson Hospital
  • Dept. Hematol., Clin. Immunol., B.
  • Worldwide Innovative Network in Personalized Cancer Medicine
  • University of Texas MD Anderson Cancer Center
  • UC San Diego Moores Cancer Center
  • University of Tübingen
  • Universidade Estadual de Campinas
  • American Society of Clinical Oncology
  • Department of Clinical Immunology and Biological Therapy
  • Clinical Immunology
  • University of Vienna
  • The University of Chicago
  • Johns Hopkins University
  • Fox Chase Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Shanghai Jiao Tong University
  • Rambam Health Care Campus Israel
  • Tel Hashomer Hospital
  • Center for Personalized Therapy Clinical Trials Office
  • Houston Clinical Trials
  • University of California Office of the President
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • UCSD Moores Cancer Center
  • University of California at San Diego Moores Cancer Center
  • Division of Hematology and Oncology
  • University of San Diego
  • UCSD Moores Cancer Center
  • Center for Personalized Cancer Therapy
  • UC San Diego Medical Center
  • Johnson & Johnson
  • Department of Hematology
  • Department of Bioimmunotherapy
  • Department of Medicine
  • Division of Hematology and Oncology
  • Moores Cancer Center
  • Department of Molecular Oncology
  • Departments of Clinical Immunology and Biological Therapy
  • Center for Personalized Therapy and Clinical Trials Office
  • Phase I Program
  • Center for Personalized Cancer Therapy
  • Experimental Therapeutics Program
  • Moores Cancer Center
  • Department of Investigational Cancer Therapeutics
  • Department of Leukemia
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Internal Medicine
  • Department of Medicine
  • Department of Breast Medical Oncology
  • The Departments of Clinical Investigation
  • Department of Leukemia
  • Phase I Program, Department of Investigational Cancer Therapeutics
  • Department of Medicine
  • Department of Cell Biology
  • Center for Personalized Therapy and Clinical Trials
  • Department of Gastrointestinal Medical Oncology
  • Department of Hematology and Bone Marrow Transplantation
  • Division of Hematology and Oncology
  • Department of Experimental Therapeutics
  • Cell Growth Regulation Laboratory
  • Department of Medical Oncology
  • Division of Hematology-Oncology
  • Moores Cancer Center
  • Departments of Medical Ontology
  • UC San Diego
  • Division of Hematology and Oncology
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Clinical Center for Targeted Therapy
  • Phase 1 Program
  • Department of Bioimmunotheraphy
  • Department of Clinical Investigations
  • Department of Bioimmunotherapy
  • Dpt. Clin. Immun./Biol. Therap
  • Section of Bone Marrow Transplantation
  • Department of Cancer Medicine
  • Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
  • Departments of Leukemia and Bioimmunotherapy
  • Department of Biologic Studies
  • Departments of Neurosurgery and Hematopathology
  • Dept. of Clinical Investigations
  • Departments of Internal Medicine I and Nuclear Medicine
  • Dept. Clin. Immun./Biol. Ther.
  • Department of Clinical Investigation
  • Department of Oncology
  • M.D. Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics
  • Department of Experimental Therapeutics
  • Departments of Experimental Therapeutics
  • Department of Hematology and Oncology
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Investigational Cancer Therapeutics-a Phase I
  • UC San Diego Moores
  • Center for Personalized Therapy
  • Division of Hematology/Oncology
  • Moores Cancer Center
  • Worldwide Innovative Network (WIN) Association–WIN Consortium
  • Department of Hematology/Oncology
  • University of California at Berkeley
  • Division of Hematology and Oncology
  • Repligen Corporation
  • Exelixis Inc.
  • Biological Therapy
  • Department of Clinical Immunology and Biological Therapy
  • WIN Consortium
  • University of Texas System
  • American Society of Clinical Oncology
  • WIN Consortium
  • WIN Consortium
  • Medical College of Wisconsin
  • University of Nebraska Omaha
  • Section of Leukocyte Biology
  • WIN Consortium for Precision Medicine

External person

Gerald S. Falchook

  • University of Texas MD Anderson Cancer Center
  • University of Texas, M.D. Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
  • Clinical Trials Program
  • The University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine
  • University of Texas at Austin
  • Department of Investigational Cancer Therapeutics
  • Unit 455
  • University of Texas M.D. Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • Sarah Cannon Research Institute at Healthone
  • The University of Texas M.D. Anderson Cancer Center
  • Sarah Cannon Research Institute at HealthONE, Presbyterian/St. Luke's Medical Center
  • Institute at HealthONE
  • Sarah Cannon Research Institute at Health ONE, Presbyterian/St. Luke's Medical Center
  • Sarah Cannon Research Institute
  • FC8.2018
  • FC8.2057
  • U.T. MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Houston Clinical Trials
  • HealthOne
  • Presbyterian-St. Luke's Medical Center
  • Sarah Cannon Research Institute
  • Unit 455
  • University of California at San Diego
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Sarah Cannon Research Institute at HealthONE
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Sarah Cannon Research
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Investigational Cancer Therapeutics-a Phase I
  • Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)
  • Drug Development Program
  • Drug Development Unit
  • HealthOne
  • Sarah Cannon Research Institute
  • Drug Development Program
  • University of Texas Health Science Center at Houston

External person

Jing Gong

  • University of Texas Health Science Center at Houston
  • Huazhong University of Science and Technology
  • Department of Biochemistry and Molecular Biology
  • Department of Epidemiology and Biostatistics
  • MOE Key Laboratory of Bioinformatics
  • Tsinghua University
  • Center for Synthetic and Systems Biology
  • Tsinghua-Peking Center for Life Sciences
  • Department of Epidemiology and Biostatistics
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Huazhong Agricultural University

External person

Sijin Wen

  • UT MD Anderson Cancer Center
  • M. D. Anderson Cancer Center
  • West Virginia University
  • West Virginia University Health Science Center
  • University of Texas M.D. Anderson Cancer Center
  • Universidade de São Paulo
  • Univ. TX M.D. Anderson Cancer Ctr.
  • MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Unit 1374
  • University of Texas MD Anderson Cancer Center
  • Dana-Farber Cancer Institute
  • University of Texas at Houston
  • University of Texas at Austin
  • David H. Koch Center for Applied Research of Genitourinary Cancers
  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Quantitative Sciences Division
  • Department of Biostatistics
  • Department of Biostatistics
  • Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
  • Department of Biostatistics
  • Department of Biostatistics
  • Department of Biostatistics
  • Departments of Neurosurgery and Hematopathology
  • Departments of Biostatistics
  • Department of Biostatistics
  • School of Public Health
  • Mary Babb Randolph Cancer Center
  • Department of Genitourinary Medical Oncology
  • Department of Biostatistics
  • University of Montreal
  • Memorial Sloan-Kettering Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • Ludwig Center for Cancer Immunotherapy
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Joud Hajjar

  • Virginia Commonwealth University
  • Baylor College of Medicine
  • Texas Children's Hospital
  • Section of Immunology
  • Department of Immunology
  • Departments of Internal Medicine
  • Department of Immunology Allergy and Rheumatology
  • Texas Children's Hospital Houston

External person

Kyriakos P. Papadopoulos

  • START Center for Cancer Care
  • Center for Cancer Care
  • South Texas Accelerated Research Therapeutics (START)
  • University of South Florida
  • South Texas Accelerated Research Therapeutics
  • South Texas Accelerated Research Therapeutics
  • Astellas Pharma Inc.
  • Clinical Research
  • South Texas Accelerated Research Therapeutics
  • Vanderbilt University
  • Institute for Drug Development
  • University of Texas Health Science Center at San Antonio
  • START
  • Clinical Research
  • South Texas Accelerated Research Therapeutics
  • Hematology/Oncology

External person

Ignacio Garrido-Laguna

  • University of Texas MD Anderson Cancer Center
  • Johns Hopkins University School of Medicine
  • Unit 455
  • University of Utah
  • University of Texas M.D. Anderson Cancer Center
  • FC8.2057
  • Johns Hopkins University
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Huntsman Cancer Institute
  • Huntsman Cancer Institute
  • Sol Goldman Pancreatic Cancer Research Center
  • Deparment Medical Oncology
  • Department of Medicine
  • Department of Medicine (Oncology)
  • City of Hope National Med Center
  • University of Texas Health Science Center at Houston

External person

Abdulrazzak Zarifa

  • University of Texas MD Anderson Cancer Center
  • Brookdale University Hospital and Medical Center

External person

Lacey McQuinn

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • University of Evansville

External person

Karen A. Autio

  • Oregon Health and Science University
  • Memorial Sloan-Kettering Cancer Center
  • Weil Cornell Medical College
  • Cornell University
  • Genitourinary Oncology Service
  • Department of Medicine

External person

Patricia LoRusso

  • Karmanos Cancer Institute/Wayne State University
  • Wayne State University
  • Karmanos Cancer Institute
  • Barbara Ann Karmanos Cancer Center
  • Wayne State University-Barbara Ann Karmanos Cancer Institute
  • Baylor Health Care System
  • Karmanos Cancer Center
  • Pinnacle Oncology Hematology
  • Yale University
  • Yale Cancer Center
  • Department of Medical Oncology
  • Phase i Clinical Trials Program
  • Eisenberg Center for Translational Therapeutics
  • Yale School of Medicine
  • Department of Medical Oncology
  • Department of Breast Medical Oncology
  • Yale New Haven Health System
  • Smilow Cancer Hospital at Yale-New Haven

External person

Annie Hung

  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Biostatistics

External person

Johanna C. Bendell

  • Sarah Cannon Research Institute
  • Tennessee Oncology
  • GI Oncology Research
  • SCRI
  • Drug Development Program
  • Duke University
  • Department of Pathology
  • Tennessee Oncology PLLC
  • SCRI, Tennessee Oncology, PLLC
  • Department of Pathology
  • Sarah Cannon Research Institute
  • Sarah Cannon
  • Tennessee Oncology PLLC
  • F. Hoffmann-La Roche AG

External person

Martin Oft

  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Synthkine
  • Pre-Clinical and Clinical Development
  • a wholly owned subsidiary of Eli Lilly and Company

External person

Yang Ye

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics
  • M. D. Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Anas Alshawa

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Rabih Said

  • University of Texas Health Science Center at Houston
  • Department of Internal Medicine
  • The University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • University of Balamand
  • Department of General Internal Medicine
  • Department of Oncology
  • Department of Internal Medicine
  • Memorial Hermann Cancer Center
  • Division of Internal Medicine-Oncology
  • Saint George Hospital University Medical Center
  • Saint George Hospital University Medical Center

External person

Christian Rolfo

  • Antwerp University Hospital
  • Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital
  • Phase I- Early Clinical Trials Unit, Oncology Department and Multidisciplinary Oncology Center Antwerp (MOCA), Antwerp University Hospital
  • University of Antwerp
  • University of Colorado Denver
  • Phase I - Early Clinical Trials Unit
  • Phase I- Early Clinical Trials Unit
  • Center for Oncological Research
  • Division of Medical Oncology
  • University of Maryland, Baltimore
  • Thoracic Oncology
  • Johns Hopkins University
  • Thoracic Medical Oncology
  • Hospital Universitario de Antwerp
  • University of Colorado Anschutz Medical Campus
  • Icahn School of Medicine at Mount Sinai

External person

Hung Le

  • University of Texas MD Anderson Cancer Center
  • Biostatistics
  • Guy's and St.Thomas Hospital
  • University of Texas Health Science Center at Houston

External person

Jeffrey R. Infante

  • Sarah Cannon Research Institute
  • Sol Goldman Pancreatic Cancer Research Center
  • Tennessee Oncology
  • Tennessee Oncology PLLC
  • Wayne State University
  • SCRI
  • PLLC/SCRI
  • SCRI, Tennessee Oncology, PLLC
  • Tennessee Oncology
  • Department of Surgery
  • Department of Pathology
  • Drug Development Program
  • GI Oncology Research
  • Sarah Cannon Research Institute
  • Janssen Inc
  • Janssen Pharmaceuticals
  • Sarah Canon Research Institute
  • Tennessee Oncology PLLC
  • Johnson & Johnson

External person

Joann Lim

  • Department of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • Pharamacy Clinical Programs
  • University of Texas Health Science Center at Houston

External person

Deborah J L Wong

  • University of California at Los Angeles
  • Division of Hematology and Oncology

External person

Joseph Leveque

  • Amgen Inc.
  • Amgen Incorporated
  • ARMO BioSciencesRedwood City
  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Scientific Affairs
  • Scientific Affiars
  • University of California at Los Angeles
  • a Sanofi Company

External person

Ming Mo Hou

  • Chang Gung University
  • University of Texas MD Anderson Cancer Center
  • Division of Hematology-Oncology
  • Division of Hematology-Oncology
  • Department of Hematology and Oncology
  • University of Texas Health Science Center at Houston
  • Chang Gung Memorial Hospital

External person

Jatin J. Shah

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology
  • Inc.
  • University of Texas Health Science Center at Houston
  • Inc

External person

Kyaw Zin Thein

  • University of Texas MD Anderson Cancer Center
  • Texas Tech University Health Sciences Center
  • Division of Hematology/Oncology
  • Division of Hematology
  • Division of Internal Medicine
  • Oregon Health and Science University

External person

L. Austin Doyle

  • University of Maryland Cancer Center
  • University of Maryland, Baltimore
  • National Institutes of Health
  • Cancer Therapy Evaluation Program
  • Cancer Therapy Evaluation Program
  • Investigational Drug Branch

External person

Todd M. Bauer

  • Sarah Cannon Research Institute
  • Tennessee Oncology
  • Sarah Cannon Research Institute
  • Tennessee Oncology PLLC
  • Department of Drug Development
  • Sarah Cannon Research Institute
  • PLLC
  • Division of Medical Oncology

External person

Bulent Yilmaz

  • University of Texas MD Anderson Cancer Center

External person

Helen X. Chen

  • National Institutes of Health/National Cancer Institute
  • CTEP National Cancer Institute
  • National Institutes of Health
  • University of Texas MD Anderson Cancer Center
  • Cancer Therapy Evaluation Program
  • Investigational Drug Branch

External person

Veronica R. Holley

  • The MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Mehmet Asim Bilen

  • Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center
  • Baylor College of Medicine
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Emory University
  • Hacettepe University
  • UT MD Anderson Cancer Center
  • Section of Geriatrics
  • Department of Hematology and Medical Oncology
  • Department of Internal Medicine
  • School of Medicine
  • Univ. Texas MD Anderson Cancer Cent.
  • Department of Hematology and Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Patrick A. Ott

  • New York University
  • Dana-Farber Cancer Institute
  • Dana-Farber/Brigham and Women's Cancer Center
  • Melanoma Center
  • Perlmutter Cancer Institute
  • Department of Medical Oncology
  • Center for Immuno-Oncology
  • Department of Hematology/Oncology
  • Vanderbilt University
  • Dana-Farber/Brigham and Women's Cancer Center
  • Dana-Farber/Brigham and Women’s Cancer Center
  • Harvard University
  • Broad Institute
  • 25Dana-Farber/Brigham and Women's Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center
  • Brigham and Women’s Hospital

External person

Kirk S. Culotta

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Biology
  • Experimental Therapeutics
  • Pharmacy Pharmacology Research
  • Department of Experimental Therapeutics
  • Merck
  • University of Texas Health Science Center at Houston
  • Experimental Therapeutics

External person

Yunfang Jiang

  • University of Texas at Austin
  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • U.T. MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Shumei Kato

  • Department of Medicine
  • University of California at San Diego
  • Center for Personalized Therapy and Clinical Trials
  • Department of Medical Oncology
  • Moores Cancer Center
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • Department of Medicine
  • Division of Hematology and Oncology
  • Center for Personalized Cancer Therapy
  • University of Texas MD Anderson Cancer Center

External person

Alexander I. Spira

  • Virginia Cancer Specialists
  • US Oncology, Inc.
  • US Oncology Research
  • US Oncology Research
  • American Society of Clinical Oncology
  • Oncology Program
  • University of Michigan, Ann Arbor
  • US Oncology, Inc.
  • Johns Hopkins University
  • US Oncology Network
  • VA
  • Virginia Cancer Specialists and US Oncology Research
  • American Society of Clinical Oncology
  • Virginia Cancer Specialists and NEXT Oncology Virginia
  • Thoracic and Phase I Program
  • Virginia Cancer Specialists
  • US Oncology Network
  • Co-Director

External person

Stacie Bean

  • University of Texas MD Anderson Cancer Center
  • Pharamacy Clinical Programs
  • Department of Pharmacy

External person

Vanda M. Stepanek

  • University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • FC8.2018
  • University of Texas MD Anderson Cancer Center
  • Rice University
  • M.D. Anderson Cancer Center
  • Department of Bioengineering
  • Department of Head and Neck Surgery
  • University of Texas Health Science Center at Houston
  • Rice University

External person

Nai Yi Shi

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Abulrahman Abonofal

  • University of Texas MD Anderson Cancer Center
  • West Virginia University

External person

Cynthia Uehara

  • Department of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center

External person

Roman Groisberg

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Medical Oncology
  • Rutgers Cancer Institute of New Jersey
  • Department of Medical Oncology
  • Rutgers - The State University of New Jersey, New Brunswick
  • University of Texas Health Science Center at Houston
  • Rutgers Cancer Institute of New Jersey
  • Cancer Institute of New Jersey
  • Rutgers University
  • Merck

External person

Roman Yelensky

  • Foundation Medicine
  • University of California at San Diego
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Department of Clinical Development
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Inc.

External person

Fechukwu Omolara Akhmedzhanov

  • University of Texas MD Anderson Cancer Center

External person

Thorunn Helgason

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Raid Aljumaily

  • Sarah Cannon Research Institute
  • University of Oklahoma
  • Department of Internal Medicine
  • Stephenson Cancer Center
  • Sarah Cannon Research Institute
  • Oncology
  • Oklahoma University
  • OUHSC

External person

Michael B. Atkins

  • Harvard University
  • Georgetown University
  • Tufts University
  • Division of Hematology-Oncology
  • Eastern Oncology Group
  • University of Michigan, Ann Arbor
  • Dana-Farber/Harvard Cancer Center
  • Department of Medicine
  • Division of Hematology-Oncology and Cancer Biology
  • Hematology-Oncology Division
  • Department of Hematology and Oncology
  • Division of Hematology and Oncology
  • Center for Melanoma
  • Division of Hematology Oncology
  • Beth Israel Deaconess Medical Center
  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Biol. Therapy/Cutaneous Oncol. Prog.
  • American Society of Clinical Oncology
  • Georgetown-Lombardi Cancer Center
  • Department of Oncology
  • Yeshiva University
  • American Society of Clinical Oncology
  • Beth Israel Deaconess Medical Center
  • Georgetown-Lombardi Cancer Center
  • Massachusetts General Hospital Cancer Center
  • MedStar Georgetown University Hospital

External person

Kevin B. Kim

  • California Pacific Medical Center
  • Melanoma Clinical Research Program
  • University of Texas MD Anderson Cancer Center
  • Melanoma Clinical Research Program
  • University of Texas Health Science Center at Houston
  • The University of Texas MD Anderson Cancer Center

External person

Murat Ak

  • University of Pittsburgh

External person

Zhijie Wang

  • Peking University Cancer Hospital and Institute
  • Department of Thoracic Medical Oncology
  • Chinese Academy of Medical Sciences
  • University of Texas MD Anderson Cancer Center
  • Translational Research (Ministry of Education
  • Peking University
  • Ministry of Education, China
  • State Key Laboratory of Molecular Oncology
  • Key Laboratory of Carcinogenesis
  • Department of Thoracic Medical Oncology
  • Department of Thoracic Medical Oncology
  • Department of Medical Oncology
  • Department of Thoracic Medical Oncology
  • Department of Thoracic Medical Oncology
  • Department of Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Joann Aaron

  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • University of Texas M.D. Anderson Cancer Center
  • M D Anderson Cancer Center
  • UT MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Community Oncology
  • University of Texas Health Science Center at Houston

External person

Manish R. Patel

  • Florida Cancer Specialists
  • Sarah Cannon Research Institute
  • Ohio State University
  • Sarah Cannon Research Institute
  • Sarah Cannon Research Institute
  • Drug Development Unit
  • Sarah Cannon Research Institute

External person

Priyadarshini Mamindla

  • University of Pittsburgh

External person

Takeo Fujii

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Breast Medical Oncology
  • Department of Biostatistics
  • Department of Biostatistics
  • Health Science Center
  • University of Hawai'i at Mānoa

External person

Bryan J. Schneider

  • University of Michigan, Ann Arbor
  • Virginia Cancer Specialists and US Oncology Research
  • University of Michigan Rogel Cancer Center
  • Division of Pulmonary and Critical Care Medicine
  • Department of Internal Medicine

External person

Xiaochun Liu

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Prasanth Ganesan

  • University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • University of Texas Health Science Center at Houston

External person

Robert E. Brown

  • University of Texas at Austin
  • University of Texas Health Sciences Center-Medical School
  • University of Texas-Houston Medical School
  • University of Texas Health Science Center at Houston
  • University of Texas at Houston-Health Science Center
  • UT Health-Department of Pathology and Laboratory Medicine
  • MSB 2.286
  • The University of Texas Medical School
  • Baylor College of Medicine
  • Department of Pathology and Laboratory Medicine, UT Health
  • Department of Pathology and Laboratory Medicine
  • Department of Pathology and Laboratory Medicine
  • Department of Pathology
  • Department of Pathology and Laboratory Medicine
  • Department of Pathology and Laboratory Medicine
  • Department of Pathology and Laboratory Medicine
  • Dept. of Pathol. and Lab. Medicine
  • Department of Pathology
  • The Department of Pathology
  • Department of Pathology
  • Department of Pathology and Laboratory Medicine
  • Department of Pathology and Laboratory Medicine
  • UT Health McGovern Medical School
  • Internal Medicine
  • UTHealth-Medical School at Houston

External person

Erick Campbell

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

John Wright

  • Johnson and Johnson Pharmaceutical Research and Development
  • Bristol-Myers Squibb
  • National Institutes of Health, Bethesda
  • National Institutes of Health
  • University of Texas MD Anderson Cancer Center
  • SUNY Upstate Medical University
  • Johnson & Johnson
  • Cancer Therapy Evaluation Program
  • Clinical Treatment Evaluation Program
  • Clinical Trials Evaluation Program
  • Investigational Drug Branch
  • Division of Cancer Treatment and Diagnosis
  • Investigational Drug Branch
  • Harvard University
  • American College of Radiology
  • Frederick National Laboratory for Cancer Research
  • Cancer Therapy Evaluation Program
  • Leidos Inc
  • University of Texas Health Science Center at Houston
  • Massachusetts General Hospital

External person

Goran Cabrilo

  • The MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Investigational Cancer Therapeutics (Phase I Program)

External person

Denis L. Jardim

  • University of Campinas
  • Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
  • Universidade Estadual de Campinas
  • University of Texas MD Anderson Cancer Center
  • Hospital Sirio-Libanes
  • University of Texas at Austin
  • Centro de Oncologia do Paraná
  • Department of Clinical Oncology
  • Department of Clinical Medicine
  • University of Texas Health Science Center at Houston

External person

Amber M. Johnson

  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • University of Texas Health Science Center at Houston

External person

J. W. Moroney

  • University of Texas M.D. Anderson Cancer Center
  • WPAFB
  • Wright State University
  • University of Texas MD Anderson Cancer Center
  • Wright-Patterson AFB
  • Wright Patterson Medical Center
  • Department of Obstetrics and Gynecology
  • Department of Obstetrics and Gynecology
  • Departments of Gynecologic Oncology
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Wright Patterson Medical Center
  • Department of Gynecologic Oncology
  • Department of Gynecology
  • Division of Gynecologic Oncology
  • Chicago Consensus Working Group
  • University of Texas Health Science Center at Houston
  • The University of Chicago

External person

Manish R. Patel

  • Sarah Cannon Research Institute
  • Sarah Cannon Research Institute
  • Florida Cancer Specialists
  • University of Minnesota Twin Cities
  • Medical College of Wisconsin
  • Ohio State University
  • Sarah Cannon Research Institute

External person

Lei Ye

  • M.D. Anderson Cancer Center
  • Shanghai Jiao Tong University
  • Department of Endocrine Neoplasia and Hormonal Disorders
  • Division of Internal Medicine
  • Exelixis
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Chemoprevention Branch
  • The University of Chicago
  • Johns Hopkins University
  • Fox Chase Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Department of General Internal Medicine, Ambulatory Treatment and Emergency Care
  • Shanghai Key Laboratory for Endocrine Tumors
  • Shanghai Center for Endocrinology and Metabolism
  • Department of Endocrine Neoplasia and Hormonal Disorders
  • Exelixis Inc.
  • University of Texas Health Science Center at Houston

External person

Adrienne Howard

  • The University of Texas MD Anderson Cancer Center
  • The University of Texas at Houston Health Science Center
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)

External person

P. Van Vlasselaer

  • Dendreon
  • Stanford University
  • Activated Cell Therapy
  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Dendreon

External person

Savita Bidyasar

  • M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • VA Medical Center
  • University of Texas Medical Branch at Galveston

External person

Raid Aljumaily

  • University of Oklahoma
  • Sarah Cannon Research Institute

External person

Linda Zhong

  • University of Texas MD Anderson Cancer Center

External person

Agop Y. Bedikian

  • M. D. Anderson Hospital
  • M. D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Box 77
  • The University of Texas M.D Anderson Hospital and Tumor Institute at Houston
  • UT MD Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • Tumor Institute
  • Hospital Sirio-Libanes
  • M.D. Anderson Cancer Center
  • Department of Melanoma Medical Oncology
  • King Faisal Specialist Hospital and Research Section
  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center
  • Alfaisal University
  • University of Texas at Austin
  • Laboratory Medicine and Tumor Institute
  • Department of Developmental Therapeutics
  • Department of Melanoma
  • Department of Melanotna/Sarcoma
  • Departments of Developmental Therapeutics
  • Department of Breast Medical Oncology
  • Department of Melanoma/Sarcoma and Surgical Oncology
  • Department of Medical Oncology
  • Department of Medicine
  • Department of Developmental Therapeutics and Department of Medicine
  • Department of Developmental Therapeutics and Department of Radiology
  • University of Texas Health Science Center at Houston
  • King Faisal Specialist Hospital and Research Centre

External person

Israel Lowy

  • Medarex, Inc.
  • Medarex Corp.
  • Medarex Corporation
  • Regeneron Pharmaceuticals, Inc.
  • Regeneron Pharmaceuticals

External person

Christos Vaklavas

  • University of Alabama at Birmingham
  • University of Texas Health Science Center at Houston
  • Mayo Clinic Rochester, MN
  • Department of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • Department of Internal Medicine
  • Division of Pediatrics
  • Department of Hematology
  • Department of Hematology and Oncology
  • University of Utah

External person

Kristin L. Parkhurst

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Jeff Hosry

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Infectious Diseases

External person

Rajul K. Jain

  • Amgen Inc.
  • Amgen Incorporated
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center
  • Department of Investi Gational Cancer Therapeutics (Phase i Program)
  • Departments of Medicine and Pediatrics
  • University of Texas Health Science Center at Houston

External person

Aya Albittar

  • University of Texas MD Anderson Cancer Center
  • SUNY Upstate Medical University

External person

F. Hirsch

  • University of Liverpool
  • University of Colorado Cancer Center
  • University of Colorado Denver
  • Data and Safety Monitoring Board
  • University of Copenhagen
  • University of Antwerp
  • Emory University
  • University of Colorado Anschutz Medical Campus
  • University of Colorado Denver Cancer Center
  • Division of Medical Oncology
  • Harvard University
  • Department of Medicine
  • Department of Medicine
  • University of Colorado Anschutz Medical Campus
  • Division of Medical Oncology
  • Department of Medical Oncology/Pathology
  • Cancer Center
  • Department of Pathology
  • Department of Oncology
  • Department of Medicine and Pathology
  • Phase I - Early Clinical Trials Unit
  • Department of Medicine
  • Department of Medicine
  • Department of Medical Oncology
  • Department of Oncology
  • International Association for the Study of Lung Cancer
  • Department of Pathology
  • Roy Castle International Centre for Lung Cancer Research
  • Molecular Urology and Therapeutics Program
  • Department of Medicine
  • Division of Medical Oncology
  • Icahn School of Medicine at Mount Sinai
  • Center for Thoracic Oncology/Tisch Cancer Center
  • Mount Sinai Health System
  • Mount Sinai Health System
  • Winship Institute
  • Mount Sinai Hospital Medical Center
  • Tisch Cancer Institute
  • Mt. Sinai School of Medicine
  • Mt. Sinai Cancer Center
  • National Institutes of Health

External person

Philip J. Stephens

  • Wellcome Research Laboratories, London
  • Queen Mary Hospital
  • Foundation Medicine
  • Institute of Cancer Research
  • University of California at San Diego
  • Welcome Trust Sanger Institute
  • Foundation Medicine, Inc.
  • The University of Hong Kong
  • SUNY Albany
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Wellcome Sanger Institute
  • Wellcome Trust
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Cancer Genome Project
  • Cancer Genome Project
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Department of Clinical Development
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • GRAIL Inc
  • Foundation Medicine, Inc.

External person

W. Michael Korn

  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of California at San Francisco
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Department of Medicine
  • Caris Life Sciences

External person

Ming Sun

  • University of Texas MD Anderson Cancer Center
  • Nanjing Medical University
  • Department of Biochemistry and Molecular Biology
  • Department of Oncology

External person

Cristina A. Reichner

  • Georgetown University
  • Georgetown University

External person

Andrés F. Cardona

  • Instituto de Oncología Dr. Luis Razetti
  • Clinical Epidemiology Clinical Research Coordinator
  • Foundation for Clinical and Applied Cancer Research - FICMAC
  • Institute of Oncology
  • Fundacion Santa Fe de Bogota
  • Hospital National Prof A. Posadas
  • Instituto Nacional de Enfermedades Neoplásicas
  • Astorga Clínica de Oncología
  • Instituto Mexicano del Seguro Social
  • Clinical and Translational Oncology Group
  • Universidad El Bosque
  • Foundation for Clinical and Applied Cancer Research - FICMAC
  • Cl�nica del Country
  • Clinical Research and Biology Systems Department
  • Clinical and Translational Oncology Group
  • Clinical and Translational Oncology Group
  • Internal Medicine Department
  • Centro Oncología San Peregrino
  • Clinical and Translational Oncology Group
  • Instituto Oncológico Luis Razetti
  • F. Hoffmann-La Roche AG
  • Clinical and Translational Oncology Group
  • Clinical and Traslational Oncology Group
  • Country Clinic
  • Clínica Colsanitas
  • Clinical Oncology Department
  • Molecular Oncology and Biology Systems Research Group (Fox-G)
  • Fundación Santa Fe de Bogotá
  • Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center-CTIC
  • Foundation for Clinical and Applied Cancer Research (FICMAC)

External person

Alessandro Russo

  • Medical Oncology Unit
  • A.O. Papardo
  • University of Maryland, Baltimore
  • University of Messina
  • Papardo Hospital

External person

Luis H. Camacho

  • Oncology Consultants
  • Division of Clinical Research
  • University of Texas M.D. Anderson Cancer Center
  • St. Luke's Episcopal Hospital Cancer Center
  • Unit 455
  • MD Anderson Cancer Center
  • University of California at Los Angeles
  • University of Texas MD Anderson Cancer Center
  • Baylor St. Luke's Medical Center
  • St Luke's Medical Center
  • Memorial Sloan-Kettering Cancer Center
  • St. Luke's Episcopal Hospital
  • Phase I Program
  • Department of Breast Medical Oncology
  • Department of Medical Oncology
  • University of Texas Health Science Center at Houston

External person

K. Madwani

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Lilibeth Castillo

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Fengying Ouyang

  • University of Texas MD Anderson Cancer Center

External person

H. Veasey Rodrigues

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Alexandra Drakaki

  • University of California at Los Angeles

External person

Marc S. Ernstoff

  • Dartmouth College
  • University of Gottingen
  • University of Göttingen
  • Cleveland Clinic Foundation
  • University Hospitals Seidman Cancer Center
  • University Hospitals Seidman Cancer Center
  • Case Western Reserve University
  • University of Texas MD Anderson Cancer Center
  • Roswell Park Cancer Institute
  • Case Comprehensive Cancer Center
  • Section of Hematology and Oncology
  • Department of Medicine
  • Department of Hematology and Oncology
  • Roswell Park Comprehensive Cancer Center
  • University of Pittsburgh
  • Roswell Park Cancer Center
  • National Institutes of Health
  • Dartmouth Hitchcock Medical Center
  • Dartmouth-Hitchcock Clinic
  • SUNY Buffalo

External person

V. A. Miller

  • Cornell University Medical College
  • Foundation Medicine
  • Weill Med. Coll. of Cornell Univ.
  • Mem. Sloan Kettering Cancer Center
  • Memorial Sloan-Kettering Cancer Ctr.
  • Memorial Sloan-Kettering Can. Center
  • Memorial Sloan-Kettering Cancer Center
  • Mem. Sloan-Kettering Cancer Center
  • M.D. Anderson Cancer Center
  • Foundation Medicine, Inc.
  • Cornell University
  • Med. Found., Inc.
  • University of Texas MD Anderson Cancer Center
  • SUNY Albany
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Thoracic Oncology Service
  • Thoracic Surgery Service
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Division of Solid Tumor Oncology
  • Department of Surgery
  • Thoracic Oncology Service
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Molecular Biology Laboratory
  • Department of Clinical Development
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Medical Oncology/Solid Tumor Program
  • Thoracic Oncology Service, Division of Solid Tumor Oncology
  • Department of Medicine
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Department of Medicine
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc
  • Lab. for Molecular Therapeutics
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc

External person

Justin T. Moyers

  • University of Texas MD Anderson Cancer Center
  • University of California at Irvine
  • Angeles Clinic and Research Institute
  • Cedars-Sinai Medical Center

External person

Muhammad Rizwan Khawaja

  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (A Phase i Program)
  • University of Texas Health Science Center at Houston

External person

Nathaniel R. Wilson

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Zev A. Wainberg

  • University of California at Los Angeles
  • Division of Hematology/Oncology
  • Department of Radiation Oncology
  • Department of Radiation Oncology
  • Department of Radiation Oncology
  • University of Texas MD Anderson Cancer Center

External person

Shiraj Sen

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Sarah Cannon Research Institute
  • HealthOne
  • Sarah Cannon Research Institute

External person

J. Y. Fok

  • University of Texas M.D. Anderson Cancer Center
  • Clinical Trials Program
  • Unit 455
  • University of Texas MD Anderson Cancer Center
  • Houston Clinical Trials
  • Cytokine Research Laboratory
  • Department of Investigational Cancer Therapeutics-a Phase I
  • Department of Experimental Therapeutics
  • University of Texas Health Science Center at Houston

External person

J. P. Eder

  • Dana-Farber Cancer Institute
  • Harvard University
  • University of Arizona
  • Yale Cancer Center
  • Belfer Institute for Applied Cancer Science
  • Division of Adult Oncology
  • Department of Medicine (Section of Medical Oncology)
  • Yale University
  • Yale

External person

Danxia Ke

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Matthew G. Fury

  • Regeneron Pharmaceuticals
  • Regeneron Pharmaceuticals, Inc.

External person

K. Lawhorn

  • Box 80
  • Univ. of Pittsburgh Cancer Institute
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Pittsburgh
  • Departments of Thoracic/Head and Neck Medical Oncology
  • Department of Head and Neck Surgery
  • Molecular Biology Laboratory

External person

John Thompson

  • University of Washington
  • Seattle Cancer Care Alliance
  • Oncology Department
  • Seattle Cancer Care Alliance
  • Fred Hutchinson Cancer Research Center
  • Harvard University
  • National Institutes of Health
  • Frederick National Laboratory Biomedical Applications Development Center (BADC)
  • Massachusetts General Hospital Cancer Center
  • Fred Hutchinson Cancer Research Center

External person

Jennifer S. Mammen

  • University of Washington
  • Johns Hopkins University

External person

Carrie A. Cartwright

  • University of Texas MD Anderson Cancer Center
  • Department of Cancer Biology
  • Louisiana State University
  • Departments of Experimental Therapeutics
  • Cytokine Research Laboratory
  • Pharmaceutical Development Center
  • University of Texas Health Science Center at Houston

External person

S. C. Formenti

  • Texas Univ. M.D. Anderson Can. Ctr.
  • New York Univ. School of Medicine
  • University of Southern California
  • New York University
  • New York University School of Med.
  • University of Texas MD Anderson Cancer Center
  • Cornell University
  • Weill Cornell Medicine
  • Weill Cornell Medicine
  • Department of Radiation Oncology
  • Departments of Radiation Oncology and Pathology
  • Departments of Radiation Oncology
  • Department of Radiation Oncology
  • Department of Pathology
  • Department of Radiation Oncology
  • Department of Radiation Oncology and Meyer Cancer Center
  • Weil Cornell College of Medicine
  • New York Presbyterian Hospital
  • Weill Cornell
  • International Cancer Expert Corps, Inc.

External person

Selma Sulovic

  • University of Texas MD Anderson Cancer Center

External person

Jeffrey S. Weber

  • University of Southern California
  • Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU
  • University of South Florida
  • Department of Cutaneous Oncology
  • New York University
  • Ohio State University
  • Wexner Medical Center
  • Department of Medicine/Oncology
  • Department of Medicine
  • Division of Medical Oncology
  • Donald A. Adam Comprehensive Melanoma Research Center
  • National Institutes of Health
  • Surgery Branch
  • Department of Medicine

External person

Ian Chau

  • Royal Marsden Hospital, Sutton
  • Royal Marsden Hospital London
  • Department of Medicine, Royal Marsden Hospital
  • Royal Marsden Hospital Surrey
  • Royal Marsden Hospital
  • Institute of Cancer Research
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine
  • Royal Marsden NHS Foundation Trust
  • Royal Marsden Hospital
  • National Health Service
  • Department of Medicine
  • Royal Marsden Hospital
  • Department of Surgery
  • Erasmus University Rotterdam
  • Royal Marsden Hospital
  • The Institute of Cancer Research, London

External person

Laura D. Porter

  • Colon Cancer Alliance
  • DC
  • NCI Colon Task Force

External person

Muthukumar Gunasekaran

  • University of Maryland, Baltimore
  • Northwestern University

External person

Bianca D. Santomasso

  • Memorial Sloan-Kettering Cancer Center
  • Department of Neurology

External person

Maen Abdelrahim

  • Baylor College of Medicine
  • Texas A and M University System Health Science Center
  • M.D. Anderson Cancer Center
  • Orlando Regional Medical Center
  • Texas A&M University
  • Department of Internal Medicine, Baylor College of Medicine
  • M.D. Anderson Cancer Center Orlando
  • Department of Pathology
  • University of Central Florida
  • MD Anderson Cancer Center Orlando
  • Texas AandM University Health Science Center
  • Orlando Regional Health Care
  • Duke University
  • Institute of Biosciences and Technology
  • Division of Medical Oncology
  • Burnett School of Biomedical Sciences
  • Cancer Research Institute
  • Division of Medical Oncology
  • Cancer Research Institute
  • Orlando Regional Healthcare
  • Institute for Academic Medicine
  • Department of Internal Medicine
  • Center for Epigenetics and Disease Prevention
  • Inst. of Biosciences and Technology
  • Center for Translational Cancer Research
  • Dept Veterinary Physiology Pharmacol
  • Insititute for Biosciences and Technology
  • Division of Medical Oncology
  • Weill Cornell Medical College
  • Houston Methodist Weill Cornell Medical College
  • Houston Methodist
  • Weill Cornell Medical College
  • Institute of Academic Medicine and Weill Cornell Medical College
  • Cornell University
  • Houston Methodist
  • Institute of Academic Medicine

External person

Vincent Yang

  • University of Texas MD Anderson Cancer Center

External person

John Powderly

  • Carolina BioOncology Institute
  • Carolina BioOncology Institute

External person

Deby C. Ogbonna

  • University of Texas MD Anderson Cancer Center

External person

Navneet P. Ratti

  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Synthkine
  • a wholly owned subsidiary of Eli Lilly and Company

External person

Adoneca Fortier

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Carole Seigel

  • Patient/Advocacy Representative
  • University of Washington
  • MA
  • Harvard University
  • Massachusetts General Hospital Cancer Center

External person

Marta Gil-Martin

  • Autonomous University of Barcelona
  • Medical Oncology Department
  • Department of Medical Oncology
  • Bellvitge Biomedical Research Institute
  • Institute Catala Oncologia
  • University of Barcelona
  • Vall d'Hebron General Hospital
  • Hospital de Bellvitge

External person

H. Henary

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Amgen Incorporated
  • University of Texas Health Science Center at Houston

External person

Oscar Arrieta

  • Hospital Universitario de la Universidad Autónoma de Nuevo León
  • Instituto Nacional de Cancerología (INCan)
  • Instituto Nacional de Cancerologia - Mexico
  • Hospital Medica Sur Cif Biotec
  • Fox Chase Cancer Center
  • Thoracic Oncology Unit and Laboratory of Personalized Medicine
  • Thoracic Oncology Unit and Laboratory
  • Laboratory Medicine
  • Clinic of Thoracic Oncology
  • Experimental Oncology Laboratory
  • Experimental Oncology Laboratory
  • Laboratorio de Oncología Experimental
  • Unidad de Oncología Torácica
  • Departamento de Oncología Medica
  • Facultad de Medicina
  • Universidad Nacional Autónoma de México
  • División de Medicina
  • Department of Medical Oncology
  • Instituto Nacional de Ciencias
  • Department of Oncology
  • Medical Oncology Department
  • Unidad de Cáncer de Mama
  • Instituto Nacional de Cancerología (INCan)
  • Personalized Medicine Laboratory
  • INCAN
  • Thoracic Oncology Functional Unit (UFOT)
  • Universidad Nacional Autonoma de Mexico

External person

Sherry Pierce

  • M.D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer C.
  • University of Texas M.D. Anderson Cancer Center
  • Box 61
  • St. Vincent's Hospital Melbourne
  • The University of Texas M.D. Anderson Cancer Center
  • Department of Leukemia
  • Unit 428
  • University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • Univ. TX M. D. Anderson Cancer Ctr.
  • UT MD Anderson Cancer Center
  • Children's Memorial Hospital
  • M. D. Anderson Cancer Center
  • University of Washington
  • University of South Florida
  • U.T. M.D. Anderson Cancer Center
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Singapore General Hospital
  • Section of Molecular Hematology and Therapy, Department of Leukemia and Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer
  • University of Texas at Austin
  • 1515 Holcombe Blvd., Box 428, 77030
  • Department of Leukemia, Division of Cancer Medicine, University of Texas M. D. Anderson Cancer Center
  • Royal Melbourne Hospital
  • University of Texas MD Anderson Cancer Center
  • MDACC
  • Departments of Leukemia
  • Universidade Federal do Rio de Janeiro
  • Department of Leukemia
  • Department of Leukemia
  • Departments of Leukemia
  • Departments of Leukemia, Hematopathology, Biostatistics
  • Depts. of Hematology and Pathology
  • Department of Hematology
  • Departments of Neurosurgery and Hematopathology
  • Department of Leukemia
  • Department of Leukemia and Department of Radiology
  • Depts. Hematol. and Biomathematics
  • Departments of Pediatrics and Leukemia
  • Department of Leukemia
  • Department of Stem Cell Transplantation
  • Section of Leukemia
  • Biostatistics and Biomathematics Group
  • Department of Clinical Investigations
  • Department of Hematopathology
  • Chemoprevention Branch
  • University of Texas Health Science Center at Houston
  • Department of Leukemia
  • Department of Leukemia

External person

Kenna R Mills Shaw

  • National Institutes of Health
  • University of Texas-Houston Health Science Center
  • The University of Texas - Houston Health Science Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Departments of Sheikh Khalifa Nahyan Ben Zayed
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Gastrointestinal Medical Oncology
  • Cancer Genome Atlas Program Office
  • TCGA Genome Data Analysis Center
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • University of Texas Health Science Center at Houston

External person

Jeffrey M. Caterino

  • Georgetown University
  • Wexner Medical Center
  • Ohio State University
  • Department of Emergency Medicine
  • Department of Internal Medicine
  • Department of Internal Medicine

External person

Kelly J. Brassil

  • University of Texas MD Anderson Cancer Center
  • Division of Nursing
  • University of Texas Health Science Center at Houston
  • Pack Health
  • A Quest Diagnostics Company

External person

Tiffiny L. Jackson

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Henrique A. Parsons

  • University of Texas Health Science Center at Houston
  • University of Texas M.D. Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics, University of Texas, M. D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Ottawa
  • Department of Palliative Care and Rehabilitation Medicine
  • Department of Medicine/Division of Palliative Care

External person

Tanyanika Phillips Towe

  • MetroHealth Medical Center, Case Western Reserve University
  • Case Western Reserve University
  • MetroHealth Medical Center Cleveland
  • University of Oklahoma
  • Stephenson Cancer Center
  • City of Hope National Med Center
  • City of Hope
  • University of Bern

External person

Christina Lacchetti

  • American Society of Clinical Oncology
  • Baylor College of Medicine
  • Johns Hopkins University
  • American Society of Clinical Oncology
  • VA
  • American Society of Clinical Oncology

External person

Howard Burris

  • Sarah Cannon Research Institute
  • Sarah Cannon Cancer Center
  • Drug Metabolism and Pharmacokinetics
  • Novartis
  • The University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Bristol-Myers Squibb
  • Tennessee Oncology
  • Tennessee Oncology PLLC
  • SCRI
  • VA Medical Center
  • Sanofi-Aventis
  • South Texas Veterans Health Care System
  • Department of Drug Development
  • Drug Metabolism and Pharmacokinetics Department
  • Department of Oncology
  • Department of Medical Oncology
  • PLLC
  • GI Oncology Research
  • PLLC
  • Sarah Cannon Research Institute
  • Drug Development
  • Sarah Cannon
  • Tennessee Oncology PLLC
  • Royal Marsden Hospital, Sutton

External person

S. Greg Call

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Elizabeth Stankevich

  • Regeneron Pharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.

External person

Jason J. Luke

  • Dana-Farber Cancer Institute
  • Memorial Sloan-Kettering Cancer Center
  • Harvard University
  • The University of Chicago
  • Department of Hematology/Oncology
  • Department of Health Studies
  • Department of Medicine
  • Section of Hospital Medicine
  • Department of Medicine
  • Department of Medicine
  • University of Pittsburgh

External person

Johnique T. Atkins

  • The University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Anesthesia and Critical Care
  • The University of Chicago
  • Houston Methodist
  • University of Texas Health Science Center at Houston
  • Houston Methodist

External person

I. Brana

  • Princess Margaret Cancer Centre
  • Canterbury District Health Board
  • University of Toronto
  • University Health Network
  • Autonomous University of Barcelona
  • Molecular Therapeutic Research Unit
  • Vall d'Hebron Institute of Oncology
  • Medical Oncology Department
  • Memorial Sloan-Kettering Cancer Center
  • Early Drug Development Unit (UITM)
  • Vall d'Hebron Institute of Oncology (VHIO)
  • Vall d'Hebron Institute of Oncology
  • Molecular Therapeutics Research Unit
  • Medical Oncology Department
  • VallD'hebron University Hospital
  • The University of Vic - Central University of Catalonia
  • Vall d'Hebron General Hospital
  • Princess Margaret Hospital

External person

Valentina Boni

  • START Madrid
  • University of Colorado Boulder
  • Centro Integral Oncológico Clara Campal (CIOCC)
  • Hospital Universitario HM Sanchinarro
  • START Madrid-CIOCC HM Hospital Sanchinarro
  • University of Colorado Hospital
  • Centro Integral Oncológico Clara Campal (CIOCC)
  • Hospital Universitario San Chinarro
  • University of Colorado Anschutz Medical Campus
  • Hospital Universitario Madrid Sanchinarro
  • HM Hospitales
  • HM Hospital Universitario San Chinarro
  • START Madrid-CIOCC
  • Hospital HM Universitario Sanchinarro
  • Hospital Madrid Norte Sanchinarro
  • Hospital Universitario Quirón de Madrid

External person

Mei Huang

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Monica Mita

  • Cedars-Sinai Medical Center
  • Institute for Drug Development Cancer Therapy and Research Center
  • The University of Texas Health Science Center
  • University of Texas Health Science Center at San Antonio
  • University of Texas Health Science Center-San Antonio
  • University of Texas MD Anderson Cancer Center
  • Samuel Oschin Comprehensive Cancer Institute
  • Department of Hematology Oncology
  • Institute for Drug Development
  • Institute for Drug Development
  • Samuel Oschin Comprehensive Cancer Institute
  • University of Texas Health Science Center

External person

Ly Nguyen

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Jarushka Naidoo

  • Memorial Sloan-Kettering Cancer Center
  • Johns Hopkins University
  • Royal College of Surgeons in Ireland
  • RCSI University of Health Sciences
  • Oncology

External person

Nina Bhardwaj

  • New York University
  • Department of Medicine
  • Department of Medicine
  • Department of Medicine
  • Icahn School of Medicine at Mount Sinai
  • University of Texas MD Anderson Cancer Center
  • Bristol-Myers Squibb
  • Thomas Jefferson University
  • Parker Institute for Cancer Immunotherapy
  • Rockefeller University

External person

Alessandra Cesano

  • Nodality, Inc.
  • Clinical Department
  • Nanostring Inc.
  • NanoString Technologies, Inc.
  • ESSA Pharma Inc
  • Essa Pharma Inc

External person

Patrick M. Forde

  • Johns Hopkins University

External person

Steven Seyedin

  • University of Texas MD Anderson Cancer Center
  • University of Iowa
  • Free Radical and Radiation Biology Program
  • University of California at Los Angeles
  • University of Texas Health Science Center at Houston
  • University of California at Irvine

External person

John B. Mumm

  • Univ. TX M. D. Anderson Cancer Ctr.
  • Schering Plough Biopharma
  • Box 422
  • Schering-Plough Biopharma
  • University of Texas MD Anderson Cancer Center
  • ARMO BioSciences
  • Merck
  • Eli Lilly
  • ARMO BioSciences
  • Department of Bioimmunotherapy
  • University of Texas Health Science Center at Houston

External person

Shahanavaj Khan

  • King Saud University
  • Shri Ram Group of College (SRGC)
  • Nanomedicine & Biotechnology Research Unit
  • Department of Bioscience

External person

Robert A. Newman

  • The University of Texas M.D. Anderson Cancer Center
  • TAP Pharmaceutical Products Inc.
  • UT M.D. Anderson Cancer Center
  • University of Texas at Austin
  • M. D. Anderson Cancer Center
  • Univ. Texas M. D. Anderson Can. Ctr.
  • University of Texas M.D. Anderson Cancer Center
  • Univ. Texas M. D. Anderson Cancer C.
  • University of Texas MD Anderson Cancer Center
  • The University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston
  • Tumor Institute at Houston
  • Department of Medical Oncology
  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • M.D. Anderson Cancer Center
  • Univ. of Texas M. D. A. Cancer Ctr.
  • Box 236
  • Pharmaceutical Development Center
  • Univ. Texas M.D. Anderson Cancer C.
  • Department of Experimental Therapeutics
  • Pacific Coast Hem. Onco. Group
  • Clin. Pharmacology Resource Facility
  • MDACC Pharmaceutical Development Center
  • M. D. Anderson
  • University of Texas Health Science Center at Houston
  • New Chapter Inc.
  • M. D. Anderson Hospital
  • Texas Univ. M. D. Anderson Can. Ctr.
  • U.T. M.D. Anderson Cancer Center
  • Emory University
  • Punisyn Pharmaceuticals
  • Univ. TX M. D. Anderson Cancer Ctr.
  • Univ. of TX M.D. Anderson Can. Ctr.
  • UT MD Anderson Cancer Center
  • New Chapter, Inc.
  • University of Texas MD Anderson Cancer Center
  • Clinical Investigation
  • Phoenix Biotechnology, Inc.
  • Pharmaceutical Development Center
  • Department of Clinical Investigations
  • Department of Experimental Therapeutics
  • Department of Medical Oncology
  • Cell Growth Regulation Laboratory
  • Cytokine Research Laboratory
  • Department of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Department of Thoracic
  • Department of Clinical Investigation
  • Department of Carcinogenesis
  • Cytokine Research Laboratory
  • Department of Pharmacy
  • Clinical Immunology and Biological Therapy
  • Department of Urology
  • Department of Hematology
  • Department of Medical Oncology
  • Department of Medical Oncology, Division of Medicine
  • Department of Experimental Therapeutics
  • Department of Pharmacology
  • Department of Experimental Therapeutics
  • Department of Breast Medical Oncology
  • Departments of Experimental Therapeutics
  • Department of Experimental Therapeutics
  • Dept. Thorac./Hd. Neck Med. Oncol.
  • Dept. of Clinical Investigations
  • Department of Internal Medicine
  • Section of Pharmacology
  • Department of Clinical Pharmacology
  • Dept. of Molec. Hematol. and Therapy
  • Inc
  • Inc

External person

Nataliya A. Uboha

  • University of Wisconsin Carbone Cancer Center
  • University of Wisconsin-Madison

External person

Pallavi Sachdev

  • Eisai Co., Ltd.

External person

Bruno Gomes

  • F. Hoffmann-La Roche AG

External person

Saneese Stephen

  • University of Texas MD Anderson Cancer Center
  • Department of Palliative Care and Rehabilitation Medicine
  • Department of Palliative
  • University of Texas Health Science Center at Houston

External person

Kevin Moore

  • University of California at San Diego
  • Department of Radiation Medicine and Applied Sciences
  • University of Oklahoma
  • Stephenson Cancer Center
  • Sarah Cannon Research Institute
  • Stephenson Cancer Center/Sarah Cannon Research Institute
  • Stephenson Oklahoma Cancer Center
  • Section of Gynecologic Oncology
  • Department of Gynecologic Oncology
  • Sarah Cannon Research Institute
  • Gynecologic Oncology
  • Stephenson Cancer Center
  • Stephenson Cancer Center
  • Sarah Cannon Research Institute/Tennessee Oncology
  • Gynecologic Oncology Group-Foundation (GOG-F)
  • Oklahoma City

External person

Erwin Sablon

  • Biocartis
  • Biocartis NV
  • Biocartis Group

External person

Jung Min Song

  • Cleveland Clinic Foundation

External person

Natalie Y.L. Ngoi

  • National University of Singapore
  • MOH Holdings Pte Ltd.
  • University of Texas MD Anderson Cancer Center
  • Chemoprevention Branch
  • National University Cancer Institute
  • National University Cancer Institute
  • National University Cancer Institute

External person

Ena Wang

  • Sidra Medical and Research Center
  • AbbVie
  • Immune Oncology Discovery and System Biology
  • TICA Group, LLC
  • Allogene Therapeutics
  • National Institutes of Health
  • LLC

External person

Min Ren

  • Eisai
  • Eisai Co., Ltd.
  • Department of Oncology

External person

Chia Chi Lin

  • National Taiwan University
  • University of Texas Health Science Center at San Antonio
  • Institute for Drug Development
  • Division of Radiation Oncology
  • Novartis Oncology
  • Graduate Institute of Clinical Medicine
  • Novartis

External person

Mohan Karkada

  • Harvard University

External person

Tim Wyant

  • Takeda Pharmaceutical Company Limited
  • Biolojic Design Inc

External person

Matthew H. Taylor

  • Oregon Health and Science University
  • Knight Cancer Institute
  • Case Western Reserve University
  • Division of Hematology and Medical Oncology
  • Providence Health System in Oregon
  • Providence Portland Medical Center

External person

Amy M. Weise

  • Wayne State University
  • Karmanos Cancer Institute
  • Department of Medical Oncology
  • Barbara Ann Karmanos Cancer Center

External person

Nancy G. Iskander

  • University of Texas MD Anderson Cancer Center

External person

Pascal O. Zinn

  • Baylor College of Medicine
  • Harvard University
  • University Hospital (CHUV BH19-110)
  • Dana-Farber Cancer Institute
  • University of Lausanne
  • University of Texas MD Anderson Cancer Center
  • Cancer Systems Imaging and Cancer Biology
  • Department of Neurosurgery
  • Department of Genetics
  • Department of Clinical Neurosciences
  • Department of Neurosurgery
  • Cancer Systems Imaging
  • Department of Clinical Neurosciences
  • Department of Cancer Biology
  • Department of Neurosurgery
  • Department of Radiology
  • Division of Neurosurgery
  • 11Cancer Biology
  • Departments of2Cancer Systems Imaging
  • 10Department of Neurosurgery
  • University of Pittsburgh
  • Department of Neurological Surgery
  • Department of Radiology
  • Department of Neurosurgery
  • Department of Radiation Oncology
  • Division of Pediatric Neurosurgery
  • University of Texas Health Science Center at Houston
  • Texas Children's Hospital Houston
  • Department of Neurosurgery

External person

Gopal Singh

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Sara Bedrose

  • University of Texas MD Anderson Cancer Center
  • Department of Diabetes
  • Baylor College of Medicine

External person

Manojkumar Bupathi

  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)

External person

Hossein Maymani

  • University of Texas MD Anderson Cancer Center
  • Departments of Hematology and Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Spyridon Bakas

  • University of Pennsylvania
  • Tufts University

External person

Rom S. Leidner

  • Case Western Reserve University School of Medicine
  • Case Western Reserve University
  • Providence Health System in Oregon
  • Earle A. Chiles Research Institute
  • Division of Hematology and Oncology
  • Department of Veterans Affairs Medical Center
  • Case Comprehensive Cancer Center
  • Providence Portland Medical Center
  • Providence Portland Medical Center
  • Earle A. Chiles Research Institute
  • Medical Oncology
  • Providence Cancer Center
  • Providence Cancer Institute

External person

S. N. Fessahaye

  • University of Texas MD Anderson Cancer Center

External person

Parag Mahale

  • University of Texas Health Science Center at Houston
  • The University of Texas School of Public Health
  • The University of Texas MD Anderson Cancer Center
  • Unit 1460
  • University of Texas MD Anderson Cancer Center
  • and Employee Health
  • Infection Control and Employee Health
  • The University of Texas MD Anderson Cancer Center
  • University of Texas at Austin
  • National Institutes of Health
  • Division of Cancer Epidemiology and GeneticsNational Cancer InstituteBethesda
  • Infection Control and Employee Health
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Division of Cancer Epidemiology and Genetics
  • Department of Epidemiology
  • VA Medical Center
  • Infections and Immunoepidemiology Branch
  • Center for Innovations in Quality Effectiveness and Safety
  • Department of Infectious Diseases
  • Dept of Epidemiology
  • Infections and Immunoepidemiology Branch
  • National Cancer Institute
  • Department of Veterans Affairs
  • Houston VA Center for Innovations in Quality Effectiveness
  • Infection Control and Employee Health

External person

Hamzah Abu-Sbeih

  • University of Texas MD Anderson Cancer Center
  • Department of Gastroenterology
  • Department of Gastroenterology, Hepatology, and Nutrition
  • University of Missouri at Kansas City
  • University of Texas Health Science Center at Houston
  • Division of Gastroenterology, Hepatology and Nutrition

External person

Andreas Kyvernitakis

  • University of Texas MD Anderson Cancer Center
  • and Employee Health
  • The University of Texas MD Anderson Cancer Center
  • Allegheny Health Network
  • University of Texas at Austin
  • Infection Control and Employee Health
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Internal Medicine
  • Department of Internal Medicine
  • Allegheny General Hospital
  • West Penn Allegheny Health System
  • University of Texas Health Science Center at Houston

External person

Shuang Liu

  • University of Texas MD Anderson Cancer Center
  • Utmdacc

External person

Alberto A. Goizueta

  • University of Texas MD Anderson Cancer Center

External person

P. C. Mack

  • University of California at Davis
  • University of California at Davis
  • University of California Office of the President
  • Emory University
  • Department of Medicine
  • Department of Medicine
  • Molecular Urology and Therapeutics Program
  • Division of Hematology/Oncology
  • Winship Institute
  • Tisch Cancer Institute
  • Mt. Sinai School of Medicine
  • Icahn School of Medicine at Mount Sinai

External person

Kim Margolin

  • University of Washington
  • Fred Hutchinson Cancer Research Center
  • City of Hope Cancer Center
  • City of Hope National Medical Center
  • City of Hope National Med Center
  • Stanford University
  • Seattle Cancer Care Alliance
  • City of Hope Duarte
  • Department of Medicine
  • Dept of Medical Oncology and Therapeutics Research
  • Department of Medical Oncology
  • Division of Medical Oncology
  • Dept. Hematol. Bone Marrow T.
  • Department of Medical Oncology
  • Division of Medical Oncology
  • University of Sydney
  • Yeshiva University
  • Seattle Cancer Care Alliance
  • University of Washington
  • Department of Medical Oncology
  • Saint John's Cancer Institute
  • Saint John’s Cancer Institute
  • Fred Hutchinson Cancer Research Center

External person

Ana M. González-Angulo

  • M.D. Anderson Cancer Center
  • Unit 1465
  • Mayo Clinic Rochester, MN
  • University of Michigan
  • University of Texas MD Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • University of Modena and Reggio Emilia
  • University of Münster
  • The University of Texas M.D. Anderson Cancer Center
  • The University of Chicago
  • Institut Gustave Roussy
  • Departments of Systems Biology
  • M. D. Anderson Cancer Center
  • Medical University of Graz
  • Department of Breast Medical Oncology
  • Unit 1354
  • Dubai Hospital
  • Departments of Breast Medical Oncology
  • MD Anderson Cancer Center
  • University of Texas at Austin
  • The University of Texas MD Anderson Cancer Center
  • University of Miami
  • M.D. Anderson
  • University of Texas MD Anderson Cancer Center
  • University of Michigan, Ann Arbor
  • Departments of Cancer Biology
  • Departments of Systems Biology
  • Departments of Systems Biology
  • Northwestern University
  • Departments of Breast Medical Oncology
  • Departments of Systems Biology
  • Department of Systems Biology
  • Department of Systems Biology
  • Department of Systems Biology
  • Department of Systems Biology
  • Kleberg Center for Molecular Markers
  • Department of System Biology
  • Department of Systems Biology
  • Department of Systems Biology
  • Departments of Gynecologic Oncology and Cancer Biology
  • Departments of Systems Biology
  • Molecular Biology Laboratory
  • Department of Pathology
  • Department of Surgical Oncology
  • Department of System Biology
  • Department of Surgical Oncology
  • Department of Breast Medical Oncology
  • Department of Breast Medical Oncology
  • M.D. Anderson Cancer Center
  • Authors' Affiliations: Departments of Department of Urology
  • Department of Breast Medical Oncology
  • Université Paris-Saclay
  • University of Texas Health Science Center at Houston

External person

Kurt W. Evans

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Vincenzo Adamo

  • University of Messina

External person

Su Chen

  • The University of Texas M.D. Anderson Cancer Center
  • M.D. Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology
  • Department of Molecular Genetics
  • University of Texas Health Science Center at Houston

External person

Bart Claes

  • Biocartis NV
  • Biocartis
  • KU Leuven
  • Biocartis Group
  • Vesalius Research Center

External person

John Simard

  • XBiotech USA
  • XBiotech USA
  • XBiotech USA
  • XBiotech USA

External person

Kathryn B. Bollin

  • Scripps Clinic
  • Medical Oncology
  • Scripps MD Anderson Cancer Center

External person

Carl Morrison

  • Roswell Park Cancer Institute
  • Ohio State University
  • Pathology Core Facility
  • Roswell Park Cancer Center
  • Ohio State University Hospitals
  • Ohio Stt. Univ. Compreh. Cancer Ctr.
  • Roswell Park Center Institute
  • The Ohio State University
  • Penrose St. Francis Health Services
  • OH Stt. Univ. Compreh. Cancer Center
  • Penrose Hospital
  • National Institutes of Health
  • Cancer Genome Atlas Program Office
  • Department of Molecular Virology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology
  • Department of Pathology and The Comprehensive Cancer Center
  • Division of Molecular Pathology
  • Department of Pathology
  • Division of Molecular Pathology
  • Division of Human Cancer Genetics
  • Comprehensive Cancer Center
  • Comprehensive Cancer Center
  • Division of Human Cancer Genetics
  • Department of Pathology and Laboratory Medicine
  • University of Melbourne
  • Department of Clinical Pathology
  • Inc.
  • OmniSeq Inc.
  • Vector Institute for Artificial Intelligence
  • University of Toronto

External person

Jingjin Li

  • Regeneron Pharmaceuticals, Inc.

External person

Javier Garcia-Corbacho

  • Department of Oncology
  • University of Cambridge
  • University of Barcelona
  • Hospital Clínic

External person

Hans Gelderblom

  • University Medical Centre
  • Leiden University
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Department of Clinical Oncology
  • European Osteosarcoma Intergroup
  • University of Pittsburgh

External person

Enedelia Rodriguez

  • University of Texas MD Anderson Cancer Center

External person

Kathleen M. Moore

  • University of Oklahoma
  • Sarah Cannon Research Institute
  • GOG
  • Department of Obstetrics and Gynecology
  • Department of Obstetrics and Gynecology
  • Sarah Cannon Research Institute
  • Stephenson Cancer Center
  • Stephenson Cancer Center
  • Stephenson Cancer Center/Sarah Cannon Research Institute
  • Stephenson Oklahoma Cancer Center
  • Department of OB/GYN
  • Department of Gynecologic Oncology
  • Section of Gynecologic Oncology
  • Sarah Cannon Research Institute
  • Stephenson Cancer Center
  • Stephenson Cancer Center

External person

Vaios Karanikas

  • Roche Innovation Center Zurich
  • Roche Innovation Center Zurich

External person

Eucharia C. Iwuanyanwu

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Benoit Devogelaere

  • Biocartis Group
  • Cartagenia

External person

Katherine Letourneau

  • University of Texas MD Anderson Cancer Center

External person

Ramaswamy Govindan

  • Washington University School of Medicine
  • Siteman Cancer Center, Barnes-Jewish Hospital, Washington University School of Medicine
  • Washington University St. Louis
  • Box 8056
  • Washington University Medical School
  • Alvin J. Siteman Cancer Center
  • University of Washington
  • Division of Oncology
  • Department of Medicine
  • Department of Medicine
  • School of Medicine
  • Division of Oncology
  • Department of Medical Oncology
  • Siteman Cancer Center
  • Division of Oncology
  • Siteman Cancer Center
  • Oncology Division
  • Hematology-Oncology Unit of the Department of Medicine
  • University of Wisconsin-Madison
  • Division of Oncology
  • University of Wisconsin.
  • Hematology-Oncology Unit of the Department of Medicine

External person

Divya Sakamuri

  • University of Texas MD Anderson Cancer Center

External person

Lina Altameemi

  • University of Texas MD Anderson Cancer Center
  • Hurley Medical Center
  • Michigan State University

External person

Anne Monette

  • McGill University

External person

Stephen K. Gruschkus

  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Department of Epidemiology
  • Xcenda
  • Xcenda, LLC
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston
  • Biostatistics

External person

Antonio Gonzalez-Martin

  • MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • GEICO
  • Division of Medical Oncology
  • University of Navarra
  • Grupo Español de Cáncer de Ovario (GEICO)

External person

Alan L. Myers

  • University of Texas, M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Pharmacy
  • Department of Pharmacy Research
  • University of Texas at Austin
  • Health Science Center at Houston
  • University of Texas Health Science Center at Houston
  • Department of Diagnostic and Biomedical Sciences

External person

J. Baranda

  • University of Kansas

External person

Javier Munoz

  • M.D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Hematology-Oncology
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Specialists
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Department of Hematology-Oncology
  • Banner MD Anderson Cancer Center
  • Phase I Program, Department of Investigational Cancer Therapeutics
  • Department of Hematology/Oncology
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Banner MD Anderson Cancer Center
  • Mayo Clinic Scottsdale, AZ
  • Banner Health

External person

R. B. Gaynor

  • Neon Therapeutics
  • Neon Therapeutics/BioNTech US
  • Eli Lilly

External person

Minjie Feng

  • Regeneron Pharmaceuticals, Inc.

External person

Pauline Funchain

  • Ohio State University
  • Comprehensive Cancer Center
  • Cleveland Clinic Foundation

External person

Brandon Cooper

  • University of Maryland, Baltimore

External person

Hendrik Tobias Arkenau

  • Sarah Cannon Research Institute
  • University of Oklahoma
  • Sarah Cannon Research Institute UK
  • GlaxoSmithKline
  • University College London
  • Prince of Wales Hospital
  • Institute of Cancer Research
  • Royal Marsden NHS Foundation Trust
  • Sarah Cannon Research Institute
  • Drug Development Unit
  • Sarah Cannon Research Institute
  • Drug Development Unit
  • Cancer Institute
  • Royal Marsden Hospital
  • Oncology
  • SCRI
  • The Institute of Cancer Research, London
  • UCL Cancer Institute
  • HCA Laboratories
  • Royal Marsden Hospital, Sutton
  • Ellipses Pharma

External person

Sacha Gnjatic

  • Memorial Sloan-Kettering Cancer Center
  • Ludwig Institute for Cancer Research
  • Icahn School of Medicine at Mount Sinai
  • Mem. Sloan Kettering Cancer Center
  • State University of New York at Stony Brook
  • New York Branch at Memorial Sloan-Kettering Cancer Center
  • Stony Brook University
  • University of Texas MD Anderson Cancer Center
  • Department of Medicine
  • Ludwig Institute for Cancer Research
  • Tisch Cancer Institute
  • Sect. of Hematology/Oncology
  • New York Branch
  • Cornell University
  • Ludwig Center for Cancer Immunotherapy
  • Department of Medicine
  • Immunology
  • Department of Immunology

External person

Maurie Markman

  • University of Texas MD Anderson Cancer Center
  • Cancer Treatment Centers of America
  • Drexel University
  • Department of Medical Oncology
  • Department of Clinical Research
  • UTMDACC
  • Clinical Research Division
  • American Society of Clinical Oncology
  • Department of Gynecologic Oncology
  • Department of Gynecological Medical Oncology
  • Division of Cancer Medicine
  • University of Texas at Austin
  • Department of Gynecologic Medical Oncology
  • M.D. Anderson Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Department of Medicine
  • Gynecol. Oncol. Grp. Admin. Office
  • Department of Behavioral Science-Unit 1330
  • SWOG
  • Dana-Farber Cancer Institute
  • Dana Farber Cancer Institute
  • Department of Gynecologic Malignancies
  • University of Texas Health Science Center at Houston
  • American Society of Clinical Oncology

External person

Leslie A. Fecher

  • University of Pennsylvania
  • University of Michigan, Ann Arbor

External person

Scott McCauley

  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences
  • Synthkine

External person

John Nemunaitis

  • Mary Crowley Medical Research Center
  • Mary Crowley Cancer Research Centers
  • U.S. Oncology
  • Introgen Therapeutics, Inc.
  • Fred Hutchinson Cancer Research Center
  • Baylor University
  • Baylor Health Care System
  • Texas Oncology
  • US Oncology, Inc.
  • Indiana Univ. School Medicine
  • Indiana University-Purdue University Indianapolis
  • Mary Crowley Cancer Center
  • Mary Crowley Cancer Research Centers
  • University of Texas MD Anderson Cancer Center
  • Clinical Research
  • Mary Crowley Cancer Research Centers Dallas
  • Fred Hutchison Cancer Research Center
  • Biotechwrite: Biomedical and Science Communications
  • Okayama University
  • Department of Thoracic and Cardiovascular Surgery
  • Division of Surgical Oncology
  • PRN Research Inc.
  • Walther Oncology Center
  • University of Toledo
  • Department of Medicine
  • Indiana University Bloomington
  • Department of Medical Affairs
  • University of Texas Health Science Center at Houston
  • Gradalis, Inc.
  • US Oncology, Inc.

External person

Ivan H. Chan

  • ARMO BioSciences
  • Eli Lilly
  • ARMO BioSciences

External person

J. O'Brien

  • Eisai Co., Ltd.

External person

Gennaro Ciliberto

  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli
  • IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
  • Fondazione G. Pascale
  • Scientific Directorate
  • Université de Paris
  • Istituti Fisioterapici Ospedalieri

External person

Maria Jose Serrano

  • University of Granada
  • Hospital Universitario Virgen de las Nieves
  • Biomedical Research Institute IBS-Granada

External person

Andrea Varga

  • Institut Gustave Roussy
  • Université Paris-Saclay
  • Institut Gus-tave Roussy
  • Gustave Roussy

External person

Frank Diehl

  • Deutsches Krebsforschungszentrum
  • Deutches Krebsforschungszentrum
  • Sysmex Inostics
  • German Cancer Research Center
  • Division of Applied Functional Genomics
  • Division of Functional Genome Analysis
  • Sysmex Corporation

External person

Chetna Wathoo

  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Surgical Oncology
  • University of Texas Health Science Center at Houston

External person

Nishma M. Ramzanali

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)

External person

I. A. Jaiyesimi

  • Box 61
  • Park Clinic
  • William Beaumont Hospital
  • University of Texas MD Anderson Cancer Center
  • Department of Medical Oncology
  • Department of Hematology
  • Department of Medical Oncology, Division of Medicine
  • Department of Medical Oncology
  • University of Texas Health Science Center at Houston
  • Beaumont Hospital
  • MI
  • Cancer Care Associates
  • Beaumont Hospital

External person

Haiying Sun

  • Novartis
  • Novartis USA

External person

Jing Gong

  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Diego de Miguel-Perez

  • University of Maryland, Baltimore
  • Icahn School of Medicine at Mount Sinai
  • University of Granada

External person

S. T. Kim

  • University of Texas MD Anderson Cancer Center

External person

J. Conroy

  • Roswell Park Cancer Institute
  • State University of New York at Buffalo
  • SUNY Buffalo
  • Department of Cancer Genetics
  • Inc.
  • OmniSeq Inc.
  • Inc.
  • Labcorp Oncology

External person

Gary B. Chisholm

  • University of Texas MD Anderson Cancer Center
  • University of Wisconsin-Madison
  • Department of Biostatistics
  • Departments of Gynecologic Oncology and Reproductive Medicine
  • Department of Palliative Care and Rehabilitation Medicine
  • Biostatistics
  • Department of Palliative Care
  • Hospital do Câncer de Barretos
  • Department of Biostatisitics
  • Departments of Biostatistics
  • Department of Biostatistics
  • Division of Bioinformatics and Computational Biology
  • University of Texas Health Science Center at Houston

External person

Edward B. Garon

  • University of California at Los Angeles
  • UCLA Santa Monica Hematology Oncology
  • Department of Hematology/Oncology
  • Translational Research in Oncology-US Network
  • Department of Hematology and Oncology
  • Emory University

External person

Sunjay Kaushal

  • University of Maryland, Baltimore
  • Northwestern University

External person

Terence Friedlander

  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of California at San Francisco
  • 10UCSF Helen Diller Family Comprehensive Cancer Center

External person

Daniel K. Wells

  • Parker Institute for Cancer Immunotherapy
  • Immunai

External person

Lee Rosen

  • John Wayne Cancer Institute
  • Premiere Oncology
  • UCLA Division of Hematology Oncology
  • UCLA
  • The University of Chicago
  • UCLA Department of Hematology and Oncology
  • University of California at Los Angeles
  • University of Texas MD Anderson Cancer Center
  • Premiere Oncology
  • Division of Hematology and Oncology
  • Saint John's Health Center
  • Santa Monica

External person

Dipti Jain

  • University of Texas MD Anderson Cancer Center

External person

Yali Yang

  • University of Texas MD Anderson Cancer Center

External person

Mira Ayoub

  • University of Pittsburgh

External person

Rachel W. Humphrey

  • Bristol-Myers Squibb
  • MethylGene Inc.
  • Mirati Therapeutics
  • CytomX Therapeutics

External person

Rena G. Lapidus

  • Translational Core Laboratory
  • University of Maryland, Baltimore

External person

Milan Anadkat

  • Washington University St. Louis

External person

Monalisa Ghosh

  • University of Michigan, Ann Arbor

External person

Susan Tse

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Beatrix Kotlan

  • National Institute of Oncology
  • Department of Molecular Immunology and Toxicology

External person

Marilyne Daher

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

L. Xu

  • Eisai Co., Ltd.
  • Department of Oncology

External person

L. S. Angelo

  • Box 178
  • Department of Immunology
  • Phase I Program
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Immunology
  • Department of Immunology
  • Department of Immunology
  • University of Texas Health Science Center at Houston
  • Texas Children's Hospital Houston
  • Marker Therapeutics

External person

Prasant Mohanty

  • XBiotech USA
  • XBiotech USA
  • XBiotech USA
  • XBiotech USA

External person

Chandtip Chandhasin

  • Unit 455
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Rishi Agarwal

  • University of Cincinnati
  • University of Texas MD Anderson Cancer Center
  • Department of Medicine Division of Hematology
  • Department of Medicine
  • Department of Hematology and Oncology
  • The Medical Center at Bowling Green
  • University of Texas Health Science Center at Houston

External person

Shuyang Yao

  • Capital Medical University
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Gary Palmer

  • Foundation Medicine
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc.
  • Tempus

External person

Yali Li

  • Foundation Medicine
  • Foundation Medicine, Inc.

External person

Joel Greshock

  • GlaxoSmithKline
  • University of Pennsylvania
  • Abramson Family Cancer Res. Inst.
  • Translational Medicine
  • Discovery and Translational Medicine
  • Abramson Family Cancer Research Institute
  • Neon Therapeutics
  • Neon Therapeutics/BioNTech US

External person

Umang Swami

  • University of Utah
  • UT
  • University of Iowa

External person

Vishal Peddagangireddy

  • University of Pittsburgh

External person

David Ferry

  • New Cross Hospital
  • Eli Lilly
  • New Cross Hospital
  • Royal Wolverhampton Hospitals NHS Trust

External person

Fiona C. Thistlethwaite

  • University of Manchester
  • The Christie NHS Foundation Trust

External person

Shell Laday

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Hadil Bazerbashi

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Salma K. Jabbour

  • Robert Wood Johnson Medical School, Rutgers University
  • The Johns Hopkins Hospital
  • Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey
  • University of Medicine and Dentistry of New Jersey
  • Johns Hopkins University
  • Cancer Institute of New Jersey
  • Rutgers - The State University of New Jersey, New Brunswick
  • Wake Forest University
  • University of Maryland, Baltimore
  • Department of Radiation Oncology
  • Department of Radiation Oncology
  • Department of Radiation Oncology and Molecular Radiation Sciences
  • Department of Radiation Oncology
  • Rutgers Cancer Institute of NJ
  • Rutgers University

External person

Brian A. Menegaz

  • University of Texas MD Anderson Cancer Center (MDACC)
  • University of Texas MD Anderson Cancer Center
  • Department of Sarcoma Medical Oncology
  • Immunopharmacology and Targeted Therapy Laboratory
  • Baylor College of Medicine
  • University of Texas Health Science Center at Houston

External person

Geoffrey Lowman

  • Thermo Fisher Scientific, Inc.

External person

Els Meeusen

  • CancerProbe Pty Ltd

External person

Marianne Davies

  • Yale Cancer Center
  • Yale University

External person

R. Khan

  • M. D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • Department of Gastrointestinal Medical Oncology
  • Department of Breast Medical Oncology
  • University of Texas Health Science Center at Houston

External person

Michael A. Cannarile

  • F. Hoffmann-La Roche AG

External person

Allison Bass

  • University of Texas MD Anderson Cancer Center
  • Pharamacy Clinical Programs

External person

Roosevelt Anderson

  • University of Texas MD Anderson Cancer Center
  • Department of Urology
  • Department of Urology
  • Department of Hematology
  • Departments of Urology and Pathology
  • University of Texas Health Science Center at Houston

External person

Gary K. Schwartz

  • Memorial Sloan-Kettering Cancer Center
  • Mem. Sloan Kettering Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Mem. Sloan-Kettering Cancer Center
  • Memorial Sloan-Kettering Can. Center
  • Medicine
  • Columbia University
  • Dartmouth College
  • Department of Medicine
  • Division of Hematology/Oncology
  • Department of Medicine
  • Gastrointest. Oncol. Res. Laboratory
  • Memorial Hospital Research Laboratories
  • Medical Center
  • Department of Oncology
  • Laboratory of New Drug Development
  • Department of Medicine
  • Clinical Genetics Service
  • New York University
  • Department of Medicine
  • Case Western Reserve University
  • University of Michigan, Ann Arbor

External person

Philipp Angenendt

  • Johns Hopkins University
  • Sysmex Inostics
  • University of Texas MD Anderson Cancer Center
  • Sol Goldman Pancreatic Cancer Research Center
  • Department of Gastrointestinal Medical Oncology
  • Sysmex Corporation

External person

Francesco Buemi

  • University of Messina

External person

Suzanne F. Jones

  • Sarah Cannon Research Institute
  • Sarah Cannon Cancer Center
  • Novartis
  • SCRI
  • SCRI, Tennessee Oncology, PLLC
  • University of Oxford
  • Drug Development Program
  • Sarah Cannon Research Institute
  • Royal Marsden Hospital, Sutton

External person

Jessica J. Lin

  • Harvard University
  • Department of Medicine
  • Massachusetts General Hospital Cancer Center
  • Massachusetts General Hospital

External person

Hazem El-Osta

  • University of Texas MD Anderson Cancer Center
  • Section of Hematology/Oncology
  • Baylor College of Medicine
  • University of Texas Health Science Center at Houston

External person

Van A. Trinh

  • Pharmacy Clinical Programs
  • University of Texas MD Anderson Cancer Center
  • Clinical Pharmacy Specialist
  • Department of Pharmacy Clinical Programs
  • Department of Pharmacology
  • Rheumatology and Rehabilitation Department
  • Assiut University
  • Department of Sarcoma Medical Oncology
  • Baylor College of Medicine
  • Division of Pharmacy
  • Department of Clinical Pharmacy Services
  • Department of Medical Oncology
  • University of Texas Health Science Center at Houston
  • Faculty of Medicine

External person

Nicholas Tschernia

  • University of North Carolina at Chapel Hill

External person

Felipe Soto

  • Tecnológico de Monterrey
  • University of Texas MD Anderson Cancer Center
  • Department of Pulmonary Medicine

External person

Rakesh Verma

  • ARMO BioSciences
  • a wholly owned subsidiary of Eli Lilly and Company
  • Eli Lilly

External person

E. G.E. De Vries

  • Dutch Working Party for Autologous Bone Marrow Transplant in Solid Tumours
  • University of Groningen
  • Dutch Working Party for Autologous Bone Marrow Transplant in Solid Tumours

External person

Giuseppe V. Masucci

  • Karolinska Institutet
  • Karolinska Institute
  • Department of Oncology and Pathology
  • Université de Paris

External person

Sergio Rutella

  • Nottingham Trent University

External person

Vesteinn Thorsson

  • Memorial Sloan-Kettering Cancer Center
  • Institute for Systems Biology
  • National Institutes of Health
  • Computational Biology Center
  • Cancer Genome Atlas Program Office
  • Insti-tute for Systems Biology

External person

Kevin B. Kim

  • Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • Unit 430
  • Department of Melanoma Medical Oncology
  • Departments of Melanoma Medical Oncology
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Melanoma Medical Oncology
  • Department of Medical Oncology
  • Department of Breast Medical Oncology
  • Department of Melanoma Medical Oncology
  • California Pacific Medical Center
  • University of Texas Health Science Center at Houston

External person

Minas P. Economides

  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • University of Texas Health Science Center at Houston
  • Department of Internal Medicine
  • UTHealth-Medical School at Houston
  • New York University

External person

Siwen Hu-Lieskovan

  • University of California at Los Angeles
  • Division of Hematology and Oncology
  • University of Utah
  • Parker Institute for Cancer Immunotherapy

External person

Yan Ping Zhang

  • University of Texas MD Anderson Cancer Center
  • Department of Pharmacy Research

External person

Yunyun Jiang

  • University of Texas MD Anderson Cancer Center
  • Departments of Gynecologic Oncology and Reproductive Medicine
  • University of Texas Health Science Center at Houston

External person

Praveen Vikas

  • University of Iowa
  • American Society of Clinical Oncology

External person

Geoffrey I. Shapiro

  • Harvard University
  • Dana-Farber Cancer Institute
  • Dana-Farber Cancer Institute and Harvard Medical School
  • Lowe Center for Thoracic Oncology
  • Department of Medical Oncology
  • Division of Preventive Medicine
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Divisions of Genetics and Rheumatology
  • Department of Medical Oncology
  • Department of Medicine
  • Belfer Institute for Applied Cancer Science
  • Early Drug Development Center
  • Department of Medicine
  • Department of Medical Oncology
  • Brigham and Women’s Hospital

External person

Timothy J. Looney

  • Thermo Fisher Scientific, Inc.
  • Singular Genomics

External person

Sherry Adkins

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Vivianne Vélez-Bravo

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • University of Texas Health Science Center at Houston

External person

Geert Maertens

  • Biocartis NV
  • Biocartis
  • Biocartis Group

External person

Justin Guinney

  • Sage Bionetworks
  • Fred Hutchinson Cancer Research Center
  • Director of Computational Oncology
  • University of Melbourne
  • Department of Pathology
  • Computational Oncology
  • University of Washington

External person

Yudong Wang

  • Department of Medical Oncology
  • Hebei Medical University
  • University of Texas MD Anderson Cancer Center
  • Department of Oncology

External person

Roberto Carmagnani Pestana

  • University of Texas MD Anderson Cancer Center
  • Department of Palliative Care and Rehabilitation Medicine
  • Department of Gastrointestinal Medical Oncology
  • Hospital Israelita Albert Einstein
  • University of Texas Health Science Center at Houston

External person

Danny Rischin

  • Peter Maccallum Cancer Centre
  • University of Melbourne
  • Department of Medical Oncology
  • Department of Medical Oncology

External person

John M. Kirkwood

  • Division of Infectious Diseases
  • University of Pittsburgh
  • Medicine
  • Department of Medicine
  • Division of Hematology-Oncology
  • Department of Medicine
  • Melanoma Program
  • Melanoma Program

External person

Debora De Melo Gagliato

  • University of Texas MD Anderson Cancer Center
  • Instituto de Cancer do Estado de São Paulo (ICESP)
  • University of Texas at Austin
  • Hospital Sirio-Libanes
  • Department of Breast Medical Oncology
  • Department of Clinical Oncology
  • Beneficenca Portuguesa Hospital Sao Paulo
  • University of Texas Health Science Center at Houston
  • Beneficência Portuguesa de São Paulo
  • Universidade de São Paulo

External person

Michael Stecher

  • XBiotech USA
  • XBiotech USA
  • XBiotech USA
  • XBiotech USA

External person

Jean Pierre Issa

  • Box 61
  • Univ. TX M.D. Anderson Cancer Ctr.
  • Temple University
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • The University of Texas M.D. Anderson Cancer Center
  • Johns Hopkins Univ. Med. I.
  • UT MD Anderson Cancer Center
  • Unit 425
  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • MD Anderson Cancer Center
  • University of South Florida
  • The University of Chicago
  • Univ. Texas M.D. Anderson Cancer C.
  • Roswell Park Cancer Institute
  • U. 428, 1515 Holcombe, Houston, T.
  • The Johns Hopkins University Medical Institutions
  • Box 428
  • Johns Hopkins University
  • UT M.D. Anderson Cancer Center
  • M. D. Anderson Cancer Center
  • Johns Hopkins Oncology Center
  • School of Medicine
  • Departments of Leukemia
  • University Children's Hospital
  • Univ. of Texas M. D. A. Cancer Ctr.
  • Center for Cancer Epigenetics
  • M.D. Anderson Cancer Center
  • University of Zurich
  • Fox Chase Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Cancer Medicine
  • Department of Leukemia
  • Fels Institute for Cancer Research and Molecular Biology
  • Department of Leukemia
  • Department of Leukemia
  • Fels Institute for Cancer Research and Molecular Biology
  • Oncology Center
  • Fels Institute for Cancer Research and Molecular Biology
  • Center for Cancer Epigenetics
  • Departments of Experimental Therapeutics and Leukemia
  • Cancer Biology Division
  • Department of Biochemistry
  • Cancer Epigenetics Program
  • Department of Hematology and Oncology
  • Department of Leukemia
  • Fels Institute for Cancer Research
  • Departments of Leukemia, Biostatistics, Pediatrics, and Hematopathology
  • Fels Institute
  • Molecular Biology Laboratory
  • Johns Hopkins Oncology Center
  • Department of Leukemia
  • Coriell Institute for Medical Research
  • Sidney Kimmel Comprehensive Cancer Center
  • School of Medicine
  • Coriell Institute for Medical Research

External person

Michael Millward

  • Australasian Lung Cancer Trials Group
  • Sir Charles Gairdner Hosp. Unit M503
  • Sir Charles Gairdner Hospital
  • Orlando Regional Medical Center
  • Royal Prince Alfred Hospital
  • University of Western Australia
  • Sir Charles Gairdner Hospital, University of Western Australia
  • Australasian Gastrointestinal Trials Group
  • University of Texas MD Anderson Cancer Center
  • Sydney Cancer Centre
  • University of Western Australia
  • Department of Medical Oncology
  • School of Medicine
  • Russian Ministry of Health
  • School of Medicine and Pharmacology
  • Australasian Lung Cancer Trials Group

External person

David Fabrizio

  • Tulane University
  • Department of Biochemistry and Molecular Biology
  • Foundation Medicine, Inc.
  • Foundation Medicine
  • Foundation Medicine, Inc.

External person

Michael P. Kahle

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

R. Bhatia

  • City of Hope
  • City of Hope National Medical Center
  • Cincinnati Children's Hospital Medical Center
  • City of Hope Comprehensive Cancer Center
  • City of Hope National Med Center
  • University of Alabama at Birmingham
  • St. Jude Children Research Hospital
  • Comprehensive Cancer Center
  • Division of Hematology and Oncology
  • Comprehensive Cancer Center
  • Department of Hematopoietic Stem Cell and Leukemia Research
  • Department of Medicine
  • Division of Hematology and Oncology
  • Department of Hematology & Hematopoietic Cell Transplantation
  • Department of Hematology
  • Department of Hematology and Hematopoietic Cell Transplant
  • Medical Center
  • Division of Hematology-Oncology
  • University of Birmingham
  • University of New Mexico

External person

Denise Topacio-Hall

  • Thermo Fisher Scientific, Inc.

External person

Hideki Furuya

  • Clinical and Translational Research Program
  • University of Hawai'i at Mānoa
  • Cancer Biology Program
  • Cedars-Sinai Medical Center

External person

S. Percy Ivy

  • National Institutes of Health
  • Cancer Therapy Evaluation Program
  • Investigational Drug Branch
  • Division of Cancer Treatment and Diagnosis

External person

Michael S. Rooney

  • Neon Therapeutics
  • Broad Institute
  • Neon Therapeutics/BioNTech US
  • Harvard-MIT Division of Health Sciences and Technology
  • Massachusetts Institute of Technology

External person

M. D. Hellman

  • Memorial Sloan-Kettering Cancer Center

External person

Seth Rosen

  • Hematology 'Oncology Associates of Treasure Coast
  • Hematology/Oncology Associates of Treasure Coast

External person

Les Brail

  • Eli Lilly
  • Infinity Pharmaceuticals, Inc.
  • Infinity Pharmaceuticals, Inc.
  • Erasca Inc.

External person

Rebecca Maywald

  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center
  • Molecular and Human Genetics
  • Dept. of Hum. and Molecular Genetics
  • University of Texas Health Science Center at Houston

External person

Shawn Daring

  • University of Texas MD Anderson Cancer Center

External person

David W M Tai

  • National Cancer Centre
  • Division of Medical Oncology

External person

Daniella E. Portal

  • Rutgers - The State University of New Jersey, New Brunswick
  • Cancer Institute of New Jersey

External person

M. J. Pilat

  • Wayne State University

External person

Alain C. Mita

  • Institute for Drug Development
  • University of Texas Health Science Center at San Antonio
  • Institute for Drug Development
  • University of Texas at Austin
  • Cedars-Sinai Medical Center
  • Experimental Therapeutics
  • Department of Hematology Oncology
  • Astellas Pharma Inc.
  • Samuel Oschin Comprehensive Cancer Institute
  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Texas Health Science Center

External person

Alex A. Adjei

  • Roswell Park Cancer Institute
  • Mayo Clinic Rochester, MN
  • Mayo Clinic Rochester
  • University of California Office of the President
  • Mayo Clinic College of Medicine and Science
  • Medicine Oncology
  • Division of Haematology/Medical Oncology
  • Division of Oncology
  • Division of Medical Oncology
  • Division of Medical Oncology
  • University of California at Davis
  • Cleveland Clinic Foundation

External person

Phil Mallinder

  • AstraZeneca R and D Charnwood
  • AstraZeneca
  • Medicinal Chemistry
  • Medicinal Chemistry

External person

Khalis Mustafayev

  • Infection Control and Employee Health
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Rishab Ramapriyan

  • University of Texas MD Anderson Cancer Center
  • Allegheny General Hospital
  • University of Texas Health Science Center at Houston

External person

Hecht J. Randolph

  • University of California at Los Angeles

External person

Zakaria S. Khondker

  • University of North Carolina at Chapel Hill
  • Department of Biostatistics
  • Department of Biostatistics
  • Neon Therapeutics/BioNTech US

External person

Ilian Tchakov

  • Eisai Co., Ltd.

External person

Meghan E. Bushway

  • Neon Therapeutics/BioNTech US

External person

Gloria Salvo

  • University of Texas MD Anderson Cancer Center
  • Hospital Italiano de Buenos Aires
  • Departments of Gynecologic Oncology and Reproductive Medicine
  • Department of Gynecologic Oncology & Reproductive Medicine
  • Department of Gynecology
  • University of Texas Health Science Center at Houston

External person

Rosa Mostorino

  • University of Texas MD Anderson Cancer Center

External person

Ed Fritsch

  • Neon Therapeutics/BioNTech US
  • Dana-Farber Cancer Institute
  • Broad Institute
  • Harvard University
  • Neon Therapeutics
  • Massachusetts Institute of Technology
  • Neon Therapeutics, Inc. Cambridge

External person

Pamela Munster

  • University of California at San Francisco
  • University of South Florida
  • Box 206
  • Box 271
  • Memorial Sloan-Kettering Cancer Center
  • University of California Office of the President
  • Division of Hematology and Oncology
  • Department of Hematopathology and Laboratory Medicine
  • Breast Medicine Service
  • DrugDiscovery Program
  • Department of Interdisciplinary Oncology and Biochemistry
  • Division of Hematology and Oncology
  • Eli Lilly
  • Department of Malignant Hematology and Experimental Therapeutics Program
  • Department of Hematology/Oncology
  • Vanderbilt University
  • Department of Medicine

External person

Farzana L. Walcott

  • Univ. Tex. M.D. Anderson Cancer Ctr.
  • Univ. TX M.D. Anderson Cancer Ctr.
  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Department of Breast Medical Oncology
  • AstraZeneca

External person

Manreet Randhawa

  • Beatson Oncology Centre

External person

Sachin Gupta

  • Wayne State University

External person

Srishti Abrol

  • University of Texas MD Anderson Cancer Center

External person

Neil Desai

  • Celgene Corporation
  • University of Texas M.D. Anderson Cancer Center
  • Abraxis BioScience LLC
  • M. D. Anderson Cancer Center
  • Abraxis BioScience, LLC
  • University of Texas MD Anderson Cancer Center
  • Inc.
  • Aadi Bioscience Inc
  • Aadi Bioscience Inc

External person

Laura Rubin

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Michael S. Gordon

  • John Wayne Cancer Institute
  • Pinnacle Oncology Hematology
  • University of Arizona
  • Aragen Inc
  • Premiere Oncology of Arizona
  • Indiana University-Purdue University Indianapolis
  • Kosan Biosciences, Inc.
  • Mem. Sloan Kettering Cancer Center
  • Indiana Univ. School Medicine
  • Mem. Sloan-Kettering Cancer Center
  • Indiana Univ. School of Medicine
  • Memorial Sloan-Kettering Cancer Center
  • Pinnacle Oncology Hematology
  • GlaxoSmithKline
  • Honor Health Research Institute
  • Collegeville
  • Department of Medicine
  • College of Medicine
  • Department of Medicine
  • Walther Oncology Center
  • Hematology/Oncology Section
  • Hematology-Oncology Section
  • Hematoiogy-Oncology Section
  • Saint John's Health Center
  • Department of Medicine
  • HonorHealth Research Institute
  • AZ
  • Indiana University Bloomington
  • HonorHealth, Arizona

External person

Paolo Manca

  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

External person

N. Faulkner

  • Wayne State University

External person

Jianping Zheng

  • Thermo Fisher Scientific, Inc.

External person

Marzia Pucci

  • University of Antwerp
  • University of Palermo
  • Department of Biopathology and Medical Biotechnologies
  • Phase I - Early Clinical Trials Unit
  • Department of Surgical

External person

David C. Smith

  • Division of Hematology/Oncology
  • University of Michigan, Ann Arbor
  • Comprehensive Cancer Center
  • Comprehensive Cancer Center
  • Department of Internal Medicine
  • Departments of Medicine
  • Duke University
  • Division of Pulmonary and Critical Care Medicine
  • Department of Internal Medicine
  • Department of Radiation Oncology
  • Cardiff and Vale NHS Trust

External person

Jennifer Dempsey

  • University of Texas MD Anderson Cancer Center

External person

Emma Rodriguez

  • University of Texas MD Anderson Cancer Center

External person

Mirella Nardo

  • University of Texas MD Anderson Cancer Center
  • Investigational Cancer Therapeutics

External person

Sherif G. Shaaban

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Elisa Giovannetti

  • Department of Medical Oncology, VU University Medical Center – Amsterdam
  • Vrije Universiteit Amsterdam
  • University of Pisa
  • Department of Medical Oncology
  • Cancer Pharmacology Laboratory
  • Italian Association for Cancer Research Start-Up Unit
  • VU University
  • AIRC Start-Up Unit

External person

Amy Wanamaker

  • Neon Therapeutics/BioNTech US

External person

Lisa Golden

  • Eli Lilly

External person

Ru Ching Hsia

  • University of Maryland, Baltimore

External person

Alexandra M. Adamopoulos

  • Department of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center

External person

Jeffrey D. Hartgerink

  • Rice University
  • Department of Bioengineering
  • Department of Chemistry
  • Department of Chemistry
  • Rice University

External person

Asaf Poran

  • Neon Therapeutics/BioNTech US

External person

Aparna Subramaniam

  • Departments of Sarcoma Medical Oncology
  • University of Texas MD Anderson Cancer Center

External person

Giovanni Nitti

  • University of Texas Health Science Center at Houston
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
  • Department of Cancer Biology
  • Department of Urology
  • Department of Experimental Therapeutics
  • Program in Human Biology and Patient-Based Research

External person

Vikas Dembla

  • University of Texas MD Anderson Cancer Center

External person

Indresh Kaur

  • MD Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • The University of Texas M.D. Anderson Cancer Center
  • M. D. Anderson Cancer Center
  • Enterprise Advisory Services Inc.
  • University of Texas MD Anderson Cancer Center
  • Enterprise Advisory Services, Inc.
  • Good Manufacturing Practice Laboratory
  • University of Texas Health Science Center at Houston

External person

Alizeh Yusuf

  • University of Texas MD Anderson Cancer Center

External person

A. Kumar

  • University of Arizona

External person

Shhyam Moorthy

  • University of Texas MD Anderson Cancer Center
  • Baylor College of Medicine
  • Department of Head and Neck Surgery

External person

Pablo Reclusa

  • University of Antwerp
  • Phase I - Early Clinical Trials Unit

External person

N. Kogut

  • The City of Hope-Southern California Kaiser Permanente Bone Marrow Transplant Program
  • City of Hope National Med Center

External person

Alexandra P. Cadena

  • Yale University
  • University of Texas MD Anderson Cancer Center

External person

Rena Vassilopoulou-Sellin

  • Box 15
  • Univ. of Texas M.D. Anderson C.
  • The University of Texas M.D. Anderson Cancer Center
  • Univ. TX M. D. Anderson Cancer Ctr.
  • Univ. Texas M.D. Anderson Cancer C.
  • Univ. Texas M.D. A. Cancer Center
  • Baylor College of Medicine
  • Box 435
  • University of Texas at Austin
  • Centre Hospitalier De l'Universite De Montréal
  • M.D. Anderson Cancer Center
  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center (UTMDACC)
  • Endocrinology Section
  • Univ. TX M.D. Anderson Cancer Ctr.
  • The University of Texas M.D. Anderson Cancer Center Houston
  • University of Texas MD Anderson Cancer Center
  • Rochester Univ. School of Medicine
  • Medical Ctr. of Postgrad. Education
  • Laurentian University
  • University of Rochester
  • Centrum Medyczne Ksztalcenia Podyplomowego, Warszawa
  • University of Texas
  • University of Texas MD Anderson Cancer Center
  • University of Montreal
  • Univer-sity of Texas MD Anderson Cancer Center
  • Section of Endocrinology, Department of Medical Specialties, Division of Medicine
  • Section of Endocrinology Houston
  • Division of Endocrinology
  • Department of Endocrinology
  • Section of Endocrinology
  • Department of Surgical Oncology
  • Department of Pathology
  • Department of Medical Specialties
  • Depts. of Surg. Oncol./Int. Med.
  • Sect. Endocr. Neoplasia Horm. D.
  • Section Endocrinology Div. Medicine
  • Departments of Surgical Oncology
  • Department of Head and Neck Surgery
  • Dept. Gastrointest. Oncol. Surg. O.
  • Department of Endocrinology and the Division of Pediatrics
  • University of Texas Health Science Center at Houston

External person

L. Srinivasan

  • Neon Therapeutics

External person

Jeane M. Painter

  • University of Texas MD Anderson Cancer Center

External person

T. L. Shigle

  • University of Texas MD Anderson Cancer Center
  • Department of Pharmacy Clinical Programs
  • Clinical Pharmacy Specialist
  • University of Texas Health Science Center at Houston

External person

Gale A. Granger

  • University of California
  • University of California at Irvine
  • Dept. of Molec. Biol./Biochemistry
  • Illumina, Inc.

External person

Simona Taverna

  • University of Palermo
  • Department of Biopathology and Medical and Forensic Biotechnologies, Section of Biology and Genetics, University of Palermo
  • University of Palermo
  • University of Antwerp
  • National Research Council of Italy
  • Department of Biopathology and Medical and Forensic Biotechnologies
  • Phase I - Early Clinical Trials Unit
  • Department of Biopathology and Medical Biotechnologies

External person

Lihou Yu

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Vijaykumar Holla

  • University of Texas M.D. Anderson Cancer Center
  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Cancer Biology
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Cancer Biology
  • Department of Cancer Biology
  • University of Texas Health Science Center at Houston

External person

E. Oelmann

  • AstraZeneca

External person

Amy Patel

  • University of Texas MD Anderson Cancer Center

External person

Reena H. Mistry

  • University of Texas MD Anderson Cancer Center
  • Department of Investigational Cancer Therapeutics (Phase I Program)
  • University of Texas Health Science Center at Houston

External person

Richard Carvajal

  • Memorial Sloan-Kettering Cancer Center
  • Columbia University
  • Medical Center
  • Melanoma Service
  • Laboratory of New Drug Development
  • Division of Hematology/Oncology
  • University of Texas MD Anderson Cancer Center
  • Sarcoma Service
  • Department of Medicine
  • Harvard University
  • Department of Medical Oncology
  • Clinical Genetics Service
  • New York University
  • Department of Medicine
  • Division of Hematology/Oncology
  • New York-Presbyterian/Columbia
  • Northwell Health System

External person

Ann M. Bailey

  • University of Kansas
  • UT MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Department of Pharmacology
  • Institute of Personalized Cancer Therapy
  • Sheikh Khalifa Bin Zayed Al Nahyan
  • Hormonal Oncogenesis Laboratory, Kansas Cancer Center
  • University of Texas Health Science Center at Houston

External person

Brenda Hernandez

  • University of Hawai'i at Mānoa
  • Hawaii Tumor Registry
  • Hawaii Tumour Registry
  • Cancer Epidemiology Program
  • National Institutes of Health

External person

Amanda McWatters

  • Box 355
  • Box 87
  • University of Texas M.D. Anderson Cancer Center
  • Univ. Texas M.D. Anderson Cancer C.
  • Box 173
  • University of Texas MD Anderson Cancer Center
  • Departments of Interventional Radiology
  • Department of Interventional Radiology
  • Dept. of Clinical Investigations
  • Department of Cell Biology
  • Department of Cell Biology
  • Division of Pediatrics
  • Department of Cancer Biology
  • University of Texas Health Science Center at Houston
  • Unit 173

External person

Darla Miller

  • University of Texas MD Anderson Cancer Center

External person

Adam Jassowicz

  • Heidelberg University 
  • University of Texas MD Anderson Cancer Center
  • German Cancer Research Center
  • Department of Translational Oncology
  • National Center for Tumor Diseases

External person

Shelly M. Xie

  • University of Texas MD Anderson Cancer Center

External person

Deepthi Kolli

  • Cognate Bioservices

External person

Mark B. Leick

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Georgetown University

External person

G. Falchoock

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Peter W. Laird

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
  • University of Southern California
  • Van Andel Institute
  • Keck/USC School of Medicine
  • Roswell Park Cancer Institute
  • Johns Hopkins University
  • National Institutes of Health
  • Center for Epigenetics
  • Cancer Genome Atlas Program Office
  • Epigenome Center
  • Department of Surgery
  • Kenneth Norris Jr. Compreh. C.
  • Department of Surgery
  • Department of Biochemistry and Molecular Biology
  • University of Texas MD Anderson Cancer Center
  • Van Andel Institute

External person

Marnix Bosch

  • Northwest Biotherapeutics, Inc.
  • Inc.
  • Biotherapeutics Inc.

External person

Bumyang Kim

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Health Services Research
  • Department of Clinical Revenue and Reimbursement
  • Section of Cancer Economics and Policy
  • Health Services Research
  • Section of Cancer Economics and Policy
  • Milken Family Foundation

External person

Igor Puzanov

  • Department of Medicine
  • Roswell Park Cancer Institute
  • Vanderbilt University
  • Department of Hematology and Oncology
  • Department of Medicine
  • CSC Building Roswell Park Cancer Institute
  • Roswell Park Comprehensive Cancer Center
  • Roswell Park Cancer Center
  • Clovis Oncology
  • SUNY Buffalo
  • Roswell Park Comprehensive Cancer Center

External person

Punit Prakash

  • Kansas State University
  • Johns Hopkins University
  • Kansas State University

External person

Chris Storgard

  • Biogen Idec
  • Biogen IDEC

External person

Dominik Barthelme

  • Neon Therapeutics/BioNTech US

External person

Diego de Miguel‑Perez

  • University of Maryland, Baltimore
  • Icahn School of Medicine at Mount Sinai

External person

Deborah A. Ferguson

  • Reata Pharmaceuticals, Inc.

External person

Jacques Moisan

  • Translational Innovation Platform Immuno-oncology

External person

Hendrick Soh

  • University of Texas MD Anderson Cancer Center

External person

Jia Sun

  • Department of Biostatistics

External person

Rashmi Chugh

  • University of Michigan, Ann Arbor
  • University of Michigan
  • Division of Hematology/Oncology
  • School of Medicine
  • Department of Medicine
  • Division of Molecular Medicine and Genetics
  • Department of Internal Medicine
  • Department of Internal Medicine
  • Department of Internal Medicine
  • Rogel Cancer Center
  • Division of Pulmonary and Critical Care Medicine
  • Department of Internal Medicine
  • University of Michigan
  • Dana-Farber Cancer Institute

External person

Muhammad Aminu

  • University of Texas MD Anderson Cancer Center

External person

Robert M. Prins

  • University of California at Los Angeles
  • Department of Neurosurgery
  • Department of Neurosurgery
  • Jonsson Comprehensive Cancer Center
  • Parker Institute for Cancer Immunotherapy
  • Department of Molecular and Medical Pharmacology

External person

Li Liu

  • Illumina, Inc.

External person

Soraya Zorro Manrique

  • Department of Melanoma
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Jordi Rodon Anhert

  • University of Texas MD Anderson Cancer Center

External person

Montserrat Ayala-Ramirez

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center (UTMDACC)
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Gregory L. Beatty

  • University of Pennsylvania
  • Perelman Center for Advanced Medicine
  • Perelman School of Medicine
  • Pulmonary
  • Division of Hematology-Oncology
  • Abramson Family Cancer Research Institute
  • Perelman School of Medicine
  • Division of Hematology-Oncology
  • Department of Medicine

External person

Sudha Yalamanchili

  • University of Texas MD Anderson Cancer Center

External person

Anneleis Willett

  • University of Texas MD Anderson Cancer Center

External person

Daniel Enderle

  • Exosome Diagnostics

External person

Cynthia K. Kizer

  • University of Texas MD Anderson Cancer Center

External person

Alexandros Xyrafas

  • SAKK, Switzerland
  • Swiss Group for Clinical Cancer Research
  • Novartis

External person

Hanna R.F. Dalla Pria

  • University of Iowa
  • University of Texas MD Anderson Cancer Center

External person

Ariel Peleg

  • Icahn School of Medicine at Mount Sinai

External person

Lubomir Sokol

  • Moffitt Cancer Center
  • University of South Florida
  • Medical Oncology, Hematology/Hematology Oncology, Moffitt Cancer Center
  • H. Lee Moffitt Cancer and Research Institute
  • H Lee Moffitt Cancer Center and Research Institute
  • Moffitt Cancer Center
  • Moffitt Cancer Center
  • Moffitt Cancer Center
  • Division of Malignant Hematology
  • Moffitt Cancer Center
  • Moffitt Cancer Center
  • Moffitt Cancer Center
  • Department of Malignant Hematology
  • H. Lee Moffitt Cancer Center and Research Institute
  • Department of Laboratory Medicine and Hematopathology

External person

Angelika Burger

  • Wayne State University

External person

Genevieve M. Boland

  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Harvard University
  • Cancer Genome Atlas Program Office
  • Department of Surgery
  • Department of Surgical Oncology
  • Sarcoma Research Center
  • Massachusetts General Hospital Cancer Center
  • Division of Surgical Oncology
  • Massachusetts General Hospital Cancer Center
  • Department of Surgery
  • University of Texas Health Science Center at Houston
  • Broad Institute
  • University of California at San Francisco
  • Massachusetts General Hospital
  • Massachusetts General Hospital Cancer Center
  • Brigham and Women’s Hospital

External person

Satish Dayal

  • Eisai Co., Ltd.

External person

Eric R. Molina

  • Rice University
  • Department of Bioengineering
  • University of Texas MD Anderson Cancer Center
  • Immunopharmacology and Targeted Therapy Laboratory
  • Baylor College of Medicine
  • Department of Bioengineering
  • University of Texas Health Science Center at Houston
  • Rice University

External person

Jordan Berlin

  • Vanderbilt University Medical Center
  • Vanderbilt-Ingram Cancer Center
  • Vanderbilt University
  • Medical Service
  • University of Wisconsin-Madison
  • Meriter-Madison General Hospital
  • Medical Oncology Section
  • VA Medical Center
  • Medical Oncology
  • American Society of Clinical Oncology
  • Medical Oncology
  • Vanderbilt-Ingram Cancer Center
  • Ludwig Center at Harvard
  • Department of Medicine
  • Department of Human Oncology
  • Department of Gastrointestinal Oncology
  • Department of Oncology
  • Midecal Oncology Section
  • Division of Oncology
  • the University of Wisconsin
  • Division of Oncology
  • Department of Human Oncology
  • University of Wisconsin Comprehensive Cancer
  • Department of Medicine
  • Division of Epidemiology
  • Harvard University
  • University of Wisconsin
  • Medicine
  • American Society of Clinical Oncology

External person

Hao Zhao

  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Bioinfomatics and Computational Biology
  • Department of Immunology
  • Departments of Computational Biology and Bioinformatics
  • University of Texas Health Science Center at Houston

External person

Vivek Verma

  • University of Nebraska Medical Center
  • University of Nebraska
  • Allegheny General Hospital
  • Department of Radiation Oncology
  • Department of Radiation Oncology
  • Department of Radiation Oncology
  • University of Texas MD Anderson Cancer Center
  • Affiliations of authors: Department of Radiation Oncology
  • University of Nebraska Omaha
  • Division of Radiation Oncology
  • Allegheny Health Network Cancer Institute
  • West Penn Allegheny Health System
  • University of Texas Health Science Center at Houston

External person

A. Adat

  • University of Texas MD Anderson Cancer Center

External person

Fred Zheng

  • Incyte
  • AstraZeneca

External person

Takafumi Sangai

  • University of Texas MD Anderson Cancer Center
  • National Cancer Center Japan
  • Natl. Cancer Ctr. Res. Inst. East
  • Chiba University
  • University of Texas MD Anderson Cancer Center
  • Department of General Surgery
  • Department of Surgical Oncology
  • Department of Surgical Oncology
  • Department of Breast Surgical Oncology
  • Pathology Division
  • University of Texas Health Science Center at Houston
  • Chiba Graduate School of Medicine
  • Chiba Graduate School of Medicine

External person

Lisa Marie Jordan

  • Exosome Diagnostics

External person

Luis Lara-Mejia

  • Instituto Nacional de Cancerologia - Mexico

External person

Daniela E. Egas-Bejar

  • University of Texas MD Anderson Cancer Center
  • University of California at San Diego
  • Division of Pediatrics
  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology
  • University of Texas Health Science Center at Houston

External person

Alexander Maximilian Bernhardt

  • University of Texas MD Anderson Cancer Center

External person

Debora De Melo Galgiato

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Melissa Johnson

  • Memorial Sloan-Kettering Cancer Center
  • Sarah Cannon Research Institute
  • Tennessee Oncology PLLC
  • Sarah Cannon Research Institute
  • Tennessee Oncology
  • Sarah Cannon Cancer Research Institute

External person

Liangliang Zhang

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Case Western Reserve University

External person

Patricia Bricmont

  • Otsuka Pharmaceutical Development and Commercialization, Inc.
  • Otsuka Pharmaceutical Co Ltd.

External person

Martine Extermann

  • University of South Florida
  • University of South Florida
  • Mofftt Cancer Center
  • Moffitt Cancer Center
  • Senior Adult Oncology Program

External person

E. Raymond

  • Beaujon University Hospital and INSERM U728
  • Novartis
  • Hôpital Beaujon
  • Department of Medical Oncology
  • Hôpital Saint-Joseph
  • Department of Medical Oncology
  • Hôspital Paris Saint-Joseph
  • Royal Marsden Hospital, Sutton

External person

Robert G. Mennel

  • Texas Oncology
  • Yale University
  • The University of Texas M.D. Anderson Cancer Center
  • American Society of Clinical Oncology
  • University of Texas MD Anderson Cancer Center
  • Case Western Reserve University
  • Northwestern University
  • Baylor Health Care System
  • American Society of Clinical Oncol.
  • Texas Oncology
  • American Society of Clinical Oncology
  • Yale Cancer Center

External person

Hui Shen

  • Van Andel Institute
  • Johns Hopkins University
  • Van Andel Institute
  • University of Southern California
  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Harvard University
  • Broad Institute
  • Tulane University

External person

Samantha J. Turnbull

  • Neon Therapeutics/BioNTech US

External person

Sunil Sharma

  • University of Utah
  • Memorial Sloan-Kettering Cancer Ctr.
  • Huntsman Cancer Institute at the University of Utah
  • Novartis USA
  • Nevada Cancer Institute
  • The Nevada Cancer Institute
  • Mem. Sloan Kettering Cancer Center
  • Huntsman Cancer Institute
  • Roswell Park Cancer Institute
  • Memorial Sloan-Kettering Cancer Center
  • Salix Pharmaceuticals
  • Novartis Pharmaceuticals Corporation
  • University of Arkansas for Medical Sciences
  • Huntsman Cancer Institute
  • Huntsman Cancer Institute
  • Center for Investigational Therapeutics
  • Department of Medicine
  • Center for Investigational Therapeutics
  • Division of Oncology
  • Section of Phase I
  • Division of Medical Oncology
  • Department of Internal Medicine
  • Translational Genomics Research Institute
  • Houston Methodist
  • Cancer Center
  • Salix Pharmaceuticals, Inc.
  • University of California at San Diego
  • Huntsman Cancer Institute
  • University of Uta
  • Novartis

External person

Pierre L. Triozzi

  • Wake Forest University
  • Harvard University

External person

E. M. Hersh

  • University of Texas at Austin
  • The University of Texas System Cancer Center, MD Anderson Hospital and Tumor Institute
  • M.D. Anderson Hospital
  • The University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute
  • M. D. Anderson Hospital and Tumor Institute at Houston
  • University of Texas Health Science Center at Houston
  • M. D. Anderson Hospital
  • Tumor Institute at Houston
  • M.D. Anderson Hospital and Tumor Institute
  • AmpliMed Corporation
  • Texas Medical Center
  • The University of Texas, M.D. Anderson Hospital and Tumor Institute
  • The University of Texas Medical School
  • Arizona Cancer Center
  • University of Arizona
  • University of Texas MD Anderson Cancer Center
  • Anderson Hospital
  • Department of developmental therapeutics
  • Department of Clinical Immunology and Biological Therapy
  • Medical Breast Service
  • National Institutes of Health
  • National Institutes of Health, Bethesda
  • Baylor College of Medicine
  • Departments of Clinical Immunology and Biological Therapy
  • Indiana University-Purdue University Indianapolis
  • University of Texas Health Science Center at San Antonio
  • Laboratory Medicine
  • Departments of Clinical Immunology and Biological Therapy
  • Department of Developmental Therapeutics and Department of Radiology
  • Department of Developmental Therapeutics
  • Department of Medicine
  • Departments of Microbiology and Medicine
  • Departments of Clinical Immunology and Biological Therapy
  • Department of Pharmacology
  • Department of Developmental Therapeutics and Department of Medicine
  • Departments of Pediatrics Pathology
  • Section of Hematology and Oncology
  • Department of Medicine
  • Department of Pharmacology
  • Departments of Developmental Therapeutics and Diagnostic Radiology
  • Department of Pathology
  • Medicine Branch
  • Department of Developmental Therapeutics and Diagnostic Radiology
  • Clinical Immunology and Biological Therapy
  • Leukemia Service
  • Department of Hematology and Clinical Immunology
  • Department of Internal Medicine
  • Indiana University Bloomington
  • University of Texas System
  • Lackland Air Force Base

External person

D. Dufner

  • University of Texas MD Anderson Cancer Center

External person

Daniel V T Catenacci

  • The University of Chicago
  • Department of Medicine
  • Department of Medicine
  • University of Texas MD Anderson Cancer Center
  • Department of Medicine
  • Section of Hematology/Oncology
  • Department of Medicine
  • Department of Medicine
  • Chicago Consensus Working Group

External person

Sina Jasim

  • St Louis University
  • Saint Louis University
  • Mayo Clinic Rochester, MN
  • University of Texas MD Anderson Cancer Center
  • Department of Endocrinology
  • Department of Medicine
  • Division of Endocrinology
  • Washington University St. Louis
  • Division of Oncology
  • University of Texas Health Science Center at Houston

External person

Siraj M. Ali

  • Foundation Medicine
  • 9 Cambridge Center
  • Nine Cambrige Center
  • Seven Cambridge Center
  • Whitehead Institute for Biomedical Research
  • Massachusetts Inst. Technol., N.
  • Med. Found., Inc.
  • Massachusetts Institute of Technology
  • Broad Institute
  • Foundation Medicine, Inc.
  • SUNY Albany
  • Foundation Medicine
  • Foundation Medicine
  • Department of Biology
  • Department of Biology
  • Department of Clinical Development
  • Foundation Medicine, Inc
  • 9 Cambridge Center
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Albany Medical College
  • Dept. of Pathol. and Lab. Medicine
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc
  • Foundation Medicine, Inc.
  • Foundation Medicine, Inc

External person

J. Randolph Hecht

  • University of California at Los Angeles
  • Sidra Medical and Research Center
  • Virginia Cancer Institute
  • Novartis Pharmaceuticals
  • Szent Laszlo Hospital
  • Hamilton Health Sciences
  • Bayer Schering Pharma Oy
  • University of Duisburg-Essen
  • Sarah Cannon Research Institute
  • University of Texas MD Anderson Cancer Center
  • Bayer AG
  • Kansas City Cancer Center
  • Medizinische Klinik II
  • West German Cancer Center
  • Jonsson Comprehensive Cancer Center
  • Canadian Cancer Trials Group
  • Cross Cancer Institute
  • Great Poland Centre for Oncology
  • National University of Singapore
  • Kosair Children's Hospital
  • University of Toronto
  • Sourasky Medical Centre
  • OSI Pharmaceuticals Inc.
  • Confidence Medical Centre
  • The Australasian Gastrointestinal Tumor Group
  • Divisions of Medical Oncology
  • Algoma District Cancer Program
  • Division of Hematology/Oncology
  • Department of Hematology/Oncology
  • University Health Network
  • Novartis
  • Sarah Cannon Research Institute
  • Department of Medicine
  • National University Hospital, Singapore
  • Princess Margaret Hospital
  • Oregon Health and Science University
  • National Cancer Institute of Canada Clinical Trials Group
  • Princess Margaret Hospital
  • Australasian Gastrointestinal Tumor Group

External person

Corina Andresen

  • Eisai Co., Ltd.

External person

Nashat Y. Gabrail

  • Gabrail Cancer Center

External person

M. J. Goldstein

  • Neon Therapeutics

External person

Vinod Pullarkat

  • University of Southern California
  • City of Hope Medical Center
  • City of Hope Comprehensive Cancer Center
  • City of Hope National Medical Center
  • City of Hope National Med Center
  • Department of Hematology & Hematopoietic Cell Transplantation
  • Department of Hematology and Hematopoietic Cell Transplant
  • Department of Medicine
  • Division of Hematology
  • Department of Hematology and HCT
  • Gehr Family Center for Leukemia Research
  • Hematology and Stem Cell Transplantation
  • Gehr Family Center for Leukemia Research

External person

Holly Kinahan

  • University of Texas MD Anderson Cancer Center

External person

Rena May

  • Amplimmune Inc.
  • AstraZeneca

External person

Robert D. Leone

  • Johns Hopkins University

External person

Crystal S. Denlinger

  • Fox Chase Cancer Center
  • Fox Chase Cancer Center, Department of Medical Oncology, Anxiety and Depression
  • Department of Medical Oncology
  • Department of Medical Oncology
  • Laboratory of Translational Oncology and Experimental Cancer Therapeutics

External person

Samuel J. Klempner

  • Harvard University
  • Division of Hematology-Oncology
  • Cedars-Sinai Medical Center
  • Angeles Clinic and Research Institute
  • Beth Israel Deaconess Medical Center
  • Massachusetts General Hospital
  • Massachusetts General Hospital Cancer Center

External person

Jeffrey Schneider

  • Winthrop University Hospital

External person

Stephen Scott

  • University of Texas MD Anderson Cancer Center

External person

Jing Zheng

  • Departments of Sarcoma Medical Oncology
  • University of Texas MD Anderson Cancer Center

External person

Daniel Cho

  • Harvard University
  • New York University
  • New York Medical College
  • Westchester Medical Center
  • Beth Israel Deaconess Medical Center

External person

Lauren Brusco

  • Departments of Investigational Cancer Therapeutics
  • University of Texas MD Anderson Cancer Center
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Baylor College of Medicine
  • Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
  • Lester and Sue Smith Breast Center
  • Department of Molecular and Cellular Biology
  • University of Texas Health Science Center at Houston
  • Surgical Oncology

External person

Gail Brown

  • ARMO BioSciences

External person

Marta Quiroga

  • Clínica Alemana de Santiago

External person

Lacey McQuinn

  • The University of Texas MD Anderson Cancer Center
  • University of Evansville
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Evansville
  • University of Texas Health Science Center at Houston

External person

W. E. Hoadley

  • University of Texas MD Anderson Cancer Center

External person

Roberto Borea

  • University of Antwerp

External person

Yuan Li

  • University of Texas Health Science Center at Houston

External person

Alexander Glavin

  • Thermo Fisher Scientific, Inc.

External person

Rishi Surana

  • University of Texas MD Anderson Cancer Center
  • Dana-Farber Cancer Institute

External person

Robert T. Dorr

  • The University of Arizona
  • Arizona Cancer Center
  • University of Arizona
  • AmpliMed Corporation
  • Univ. of Arizona Hlth. Sci. Center

External person

Sandra Acevedo

  • Clínica Alemana de Santiago

External person

Jonathan M. Choe

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Vandhana Ramamoorthy

  • University of Texas MD Anderson Cancer Center
  • Institute for Applied Cancer Science
  • Department of Sarcoma Medical Oncology
  • Center for Co-Clinical Trials

External person

Minny Bhatty

  • University of Texas MD Anderson Cancer Center

External person

Solmaz Sahebjam

  • University of South Florida
  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • National Institutes of Health
  • Johns Hopkins University

External person

Frank R. Vrionis

  • University of South Florida
  • Cutaneous Oncology and Neurosurgery Program

External person

J. Li

  • Regeneron Pharmaceuticals, Inc.

External person

Lawrence Fong

  • University of California at San Francisco
  • Stanford University
  • Blood Center
  • Department of Microbiology and Immunology
  • Division of Hematology and Oncology
  • Department of Medicine
  • Parker Institute for Cancer Immunotherapy

External person

Yanyan Tran

  • University of Texas MD Anderson Cancer Center

External person

Yong Wha Moon

  • Yonsei University
  • University of Texas MD Anderson Cancer Center
  • CHA University
  • National Institutes of Health
  • Department of Internal Medicine
  • Division of Endocrinology
  • Cancer Metastasis Research Center
  • Yonsei Cancer Center
  • Division of Medical Oncology
  • Center for Cancer Research
  • CHA University
  • Medical Oncology
  • National Institutes of Health
  • Division of Medical Oncology
  • Yonsei University
  • Department of Internal Medicine
  • Divison of Medical Oncology
  • Cancer Metastasis Research Center
  • Hematology and Oncology

External person

Daruka Mahadevan

  • Arizona Cancer Center
  • University of Arizona
  • University of Tennessee Health Science Center
  • The West Clinic
  • Arizona Cancer Center
  • College of Medicine
  • Health Science Center
  • University of Texas Health Science Center
  • University of Texas Health Science Center at San Antonio
  • Univ. Texas Hlth. Sci. Ctr. S. A.

External person

A. Piha Paul Sarina

  • University of Texas MD Anderson Cancer Center

External person

Carol Aghajanian

  • Memorial Sloan Kettering Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Cornell University
  • Department of Medical Oncology
  • Department of Medicine
  • Developmental Chemotherapy Service
  • University of Arizona

External person

Mehmet E. Er

  • University of Pittsburgh

External person

Pervin Hurmuz

  • Hacettepe University

External person

Sen Zhang

  • Clinical Biomarkers and Companion Diagnostics

External person

Tina Priewasser

  • Exosome Diagnostics

External person